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Flow mediated dilation (FMD) is a non-invasive test that assesses endothelial health and 
nitric oxide bioavailability; it is commonly used to examine changes in vascular health due 
to disease or de-conditioning. Currently, a wide variety of protocols are being used to 
assess upper and lower extremity conduit artery health. The current project was embarked 
upon to gain a better understanding of the FMD protocols currently being used to asses 
conduit artery FMD and how these results impact our understanding of a participant’s 
vascular health. More specifically occlusion duration, cuff placement and artery location 
were examined in three commonly examined conduit arteries. The FMD responses in the 
brachial artery (BA), superficial femoral artery (SFA), and popliteal artery (PA) of ten 
healthy men, mean age of 27 4, after five and/or two-minutes of distal occlusion were 
examined. When the two-minute protocol was performed on the SFA and PA, low-
resistance static calf exercise was added to augment the shear stimulus. It was 
hypothesized that percent FMD and shear stress responses of the SFA and PA would not be 
significantly different after five-minutes of occlusion, thereby allowing leg conduit artery 
FMD to be performed on either artery. It was further hypothesized that there would be no 
significant differences between the shear stress and percent FMD responses of the leg 
conduit arteries after five or two-minutes of occlusion; inferring that shorter occlusion 
durations when combines with ischemic muscle contractions can be used to assess SFA or 
PA FMD. With regards to comparisons between arm and leg conduit arteries, it was 
hypothesized that there would be significant between limb differences in baseline 
diameter, FMD and shear stress post five-minutes of distal occlusion. These differences will 
be used to better understand the effects of artery location and size on conduit artery FMD 
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responses. Limitations with the traditional edge-detection method of determining arterial 
diameter prompted the creation of a new method of measuring artery diameter, the center-
based method. It was hypothesized that there would be no significant differences in the 
percent FMD and time to FMD after five-minutes of BA occlusion (n=7). The results of the 
current study demonstrated that five-minutes of calf occlusion elicited a significant PA FMD 
but not a significant SFA FMD. FMD post two-minutes of PA occlusion with exercise was not 
significantly different than that produced by five-minutes of occlusion. Conversely, two-
minutes of calf occlusion with exercise was unable to elicit a SFA FMD response. Significant 
differences in shear stress and FMD were reported between arm and leg conduit arteries, 
demonstrating different responses to five-minutes of distal occlusion due to artery size and 
location. Finally, no significant differences were noted between FMD and time to FMD 
when the center-based or edge-detection method was used. This study has demonstrated 
that the calf occlusion protocol was unable to elicit a FMD response in the SFA FMD; this 
occlusion location is only able to elicit a PA FMD response. Furthermore, two-minutes of 
occlusion with one-minute of exercise can be used in place of the five-minute protocol to 
examine PA FMD but not SFA FMD. Differences between arm and leg conduit arteries are 
noted and it has been suggested that this is likely due to leg conduit artery adaptations to 
gravity. Lastly, preliminary data suggest that the center-based method is an appropriate 
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Chapter 1: Introduction 
 
Changes in arterial structure and function occur with aging, cardiovascular disease, spinal cord 
injury (67) and long-term microgravity exposure (9). Vascular health can be examined non-
invasively in large conduit arteries such as the brachial artery (BA), superficial femoral artery 
(SFA) and popliteal artery (PA). These conduit vessels are primarily responsible for supplying 
underlying tissue with blood, oxygen and nutrients. These vessels show significant decreases in 
vascular tone regulation when one of the above-mentioned conditions is present.  Assessing the 
arterial health of an individual is a good indicator of their overall cardiovascular health, because 
individuals with coronary artery disease or its associated risk factors have dramatic impairment 
of peripheral artery functioning (13).  
All of a body’s arteries, from large conduit arteries to small capillaries, are lined with a 
specialized layer of cells called endothelial cells (ECs). Furchgott & Zawadzki discovered the 
importance of the endothelium in regulating vascular homeostasis(23). It is now known that the 
endothelium is a large paracrine organ that not only plays an important role in vascular tone 
regulation but also helps regulate cell growth, inflammation and thrombosis (26). When blood 
flows past arterial walls it exerts a frictional force upon the walls termed shear stress. An 
increase in flow, and therefore shear stress, leads to the release of one or more endothelial 
derived relaxation factors (EDRF), such as nitric oxide (NO), which will induce vasodilatation. 
However, without a functional endothelium, alterations in diameter due to changes in flow will 
not occur.  NO bioavailability is commonly measured as it has been reported to decrease with 
age and various disease states, such as cardiovascular disease. Once secreted, NO diffuses out of 
EC’s and into vascular smooth muscle cells where it induces vasodilatation (68).  
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In a healthy individual, increases in blood flow are coupled with an increase in NO production 
leading to vasodilatation. This response can be examined in the laboratory with a flow-mediated 
dilation (FMD) test. This test measures changes in vessel diameter following an increase in 
blood flow; this response is significantly reduced or eliminated without a healthy and intact 
endothelium(72). Short duration occlusions of the RA, BA, SFA and PA produce a FMD 
response that is NO mediated (32; 36; 44). The magnitude of a FMD response can indicate 
endothelial function and NO bioavailability, which are both important predictors of 
cardiovascular health. A BA FMD response of less than 4% has been observed in patients with 
CVD and its associated risk factors(13). Research has demonstrated that endothelial impairment 
in the peripheral circulation occurs alongside coronary endothelial changes, suggesting that 
endothelial dysfunction is a systemic event. Therefore, using FMD to determine peripheral artery 
function is an appropriate surrogate marker of cardiac health(4).  
Since the FMD protocol was first describe by Celermajer and colleagues in 1992 this test has 
become a common method of studying endothelial function; however, inconsistencies in study 
design and protocols have made comparisons of available literature difficult (Appendix 5: Table 
6). Different research groups use different arteries, occlusion durations, pressures and cuff 
positions, among other variables.  In 2002, Corretti and colleagues created a set of guidelines for 
examining BA endothelial function and NO bioavailability (14). This document, however, only 
provides guidance for conducting a FMD test on the BA and not other conduit arteries. The 
current study examined FMD responses of three conduit arteries the brachial, the superficial 
femoral and the popliteal, in order to better understand the role of baseline diameter and artery 
location on conduit endothelial responsiveness to distal occlusion.  Furthermore, the two leg 
conduit arteries were subject to a five and two-minute occlusion in order to identify the most 
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appropriate leg conduit artery, occlusion protocol and duration for evaluating leg endothelial 
function.  
The subsequent chapter reviews the current literature and will examine the basic biology behind 
the FMD protocol, highlight the stimulus characteristics behind different FMD protocols and will 
compare the FMD protocols performed on different limbs. Lastly, the following section will 
discuss certain methodological issues that need to be taken into account when designing a FMD 










Chapter 2: Literature Review 
2.1: Vascular Structure and Function 
The control of vascular tone and blood flow involves a complex integration of neural, physical 
and chemical stimuli. Appropriate arterial tone is required to maintain and regulate vascular 
homeostasis, which is essential to maintain blood pressure and meet the body’s oxygen demands. 
Regulation of vascular tone is achieved by balancing arterial vasoconstriction and vasodilatation. 
Vasoconstriction can be increased due to elevated sympathetic nerve activity, the presence of 
vasoconstrictor autacoids or alterations in myogenic tone. Conversely, vasodilatation can be 
initiated by the presence of vasodilatory autacoids or via the attenuation of alpha-adrenergic tone 
(42). The ability to regulate vascular tone decreases with age, atherosclerosis, hypertension, 
diabetes, obesity and smoking (67). 
Arteries are capable of responding to changes in blood flow and subsequently inducing 
vasoconstriction or vasodilatation due endothelial cells (ECs).  These spindle-shaped cells line 
all of the body’s arteries and are oriented parallel to the direction of blood flow (40). Their 
location and orientation allow them to modulate vascular tone in response to alterations in flow 
(26). ECs also play an important role in arterial remodeling, inflammation and thrombosis (26). 
The importance of this monolayer of cells was first documented by Furchgott & Zawadzki who 
reported that acetylcholine (Ach) infusion with an intact endothelium produced vasodilatation; 
however, without an intact endothelium, Ach infusion produced vasoconstriction (23). Since this 
pioneering study, scientists uncovered that Ach led to vasodilatation via the NO pathway (Figure 




The peripheral arteries of individuals with atherosclerosis tend to have a dysfunctional 
endothelium and a decreased ability to release NO. Therefore, these individuals have difficulty 
regulating vascular homeostasis. For this reason, a large amount of research is being conducted 
to better understand how changes in NO-mediated vasodilation relate to arterial health.  
2.2 Nitric Oxide and Endothelial Cells  
NO is a very important EDRF that plays a role in vascular tone, immune function, cell growth, 
neurotransmission, metabolic regulation, excitation-contraction coupling and inhibition of 
platelet aggregation (35). NO is secreted and released by ECs; within an EC the true interface 
with flowing blood is the endothelial glycocalyx (GCX). Through mechanotransduction, GCX 
membrane-bound proteins sense fluid shear stress and convert that force into a biochemical 
signal that can induce changes in diameter, according to the “glypican-caveolae-eNOS 
hypothesis” (68). The shear stress stimulus is transmitted to the caveolae (68) whereby 
endothelial nitric oxide synthase (eNOS) is phosphorylated (40). Once eNOS is phosphorylated 
it translocates to the cytolsol and converts L-arginine to NO and L-citruline (Figure 1a) (4; 28). 
Many factors can alter eNOS expression including: tumor necrosis factor-  (47), erythropoietin 
(74), hypoxia (41) and high concentrations of oxidized low-density lipoproteins (38). A 
discrepancy between the amount of eNOS mRNA present in ECs and eNOS protein production 
and activity suggests that post-translational and post-transcriptional control mechanisms can alter 
eNOS mRNA stability and thus decrease eNOS expression (28). Altering the expression of 




Once NO is synthesized, it diffuses out of the EC and into vascular smooth muscle cells. Within 
the vascular smooth muscle cell NO can bind to guanylate cyclase increasing cyclic guanosine 
monophosphate which decreases intracellular calcium leading to vasodilatation (Figure 1a & 1b).  
 
Figure 1a: Nitric oxide synthesis and diffusion into smooth muscle cell to induce vasodilatation 
(4) 
 
Figure 1b: Various pathways in which nitric oxide pathway can induce vasodilatation 
Abbreviations: PiP2: Phosphatidylinositol 4,5-bisphosphate, Gq: class of G proteins, Gi, Gs: heterotrimeric G 
proteins, ATP: adenosine triphosphate, cAMP: cyclic adenosine monophosphate, cGMP: cyclic guanosine 
monophosphate, GTP:guanosine triphosphate, IP3: inositol triphosphate, DAG: diacylglycerol.  (63)  
The balance between vasodilator and vasoconstrictor autocoids regulates vascular smooth 
muscle tone. NO and other EDRF’s, such as prostacyclin and endothelium derived 
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hyperpolarizing factor, can induce vasodilatation (40). Vasocontricting autocoids such as 
vasoconstrictor prostanoids, endothelin-1, angiotensin-II and reactive oxygen species like 
superoxide anion are also secreted by the endothelium (40) and can decrease arterial diameter. 
These factors will not be discussed further as their role in short duration shear stimuli in young 
healthy individuals is believed to be negligible (32; 44).  
The production of NO and the ability for EC’s to induce vasodilatation due to this EDRF is 
integral for proper vascular responses to increased shear stress. Research has demonstrated a 
decrease in NO production and peripheral artery function in patients with CVD and its associated 
risk factors (13). This has motivated researchers to create a non-invasive method of determining 
NO release and endothelial function as a predictor of CVD. 
2.3: Non-invasive Assessment of Vascular Health 
Prior to 1992 invasive tests, such as angiography, were the primary method used to detect the 
presence of cardiovascular disease and atherosclerosis. These tests are still being used, however 
now there is a non-invasive method available for measuring vascular and endothelial health. In 
1992, Celermajer and colleagues validated the use of flow-induced changes in diameter as a 
useful non-invasive method of studying and predicting the health of the central and peripheral 
vascular system.  
FMD is accomplished by inflating a pneumatic cuff to supra-systolic pressures to produce limb 
ischemia. This ischemic environment results in distal micro-vessel dilation caused by metabolite 
accumulation. Cuff deflation induces a short duration high blood flow state through the artery 
termed reactive hyperemia (RH); this elevated blood flow is due to a decrease in resistance of 
downstream-dilated resistance vessels (14). Furthermore, RH increases wall shear stress leading 
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to the release of one or more EDRF’s from upstream arteries, which will produce significant 
changes in arterial diameter (13).  Flow mediated dilation is calculated via the following 
equation: 
Equation 1:    
Dbaseline is measured prior to cuff inflation (71) and Dpost is peak arterial diameter post cuff release.  
 
The pioneering study by Celermajer et al. examined 100 participants, ages 8-67, and classified 
them as either: healthy, having at least one risk factor for cardiovascular disease, familial history 
of hypercholesterolemia or diagnosed coronary artery disease. A significant decrease in FMD in 
patients suffering from CVD and in young symptom free individuals with risk factors for 
cardiovascular disease was reported. The FMD in the SFA of control patients was 4 1% while 
in patients with CVD, SFA FMD decreased to 1  0.3%.  The BA FMD of controls was 11  
2%, while in patients with CVD BA FMD significantly decreased to 0  1%.  In children with a 
family history of hypercholesterolemia SFA FMD was 0+1% while SFA FMD was 9+1% in 
control children(13). These results are supported by Gocke et al. who examined 35 patients with 
known CVD, and 164 age matched controls with no CVD. They reported that BA FMD 
significantly decreased to approximately 4% in patients with a cardiac event, compared to 7% in 
those who did not have a cardiac event(27). Based on this evidence it has been suggested that a 
BA FMD response of less than 4% is a good predictor of decreased endothelial function and NO 
release.   
Changes in peripheral artery vascular homeostasis are an important indicator of an individual’s 
overall cardiovascular health. This is due to the fact that peripheral changes in FMD are seen in 
both patient with CAD and in individuals with CAD associated risk factors, inferring that 
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peripheral vascular changes parallel those in the coronary circulation (4; 37). The creation and 
validation of FMD has been integral in the study of vascular and endothelial health in both 
healthy and diseased populations. There are two other non-invasive methods that can be used to 
infer endothelial function; venous occlusion plethysmography and pulse wave analysis. Briefly, 
venous occlusion plethysmography measures changes in limb volume and blood flow at rest or 
during limb occlusion, and pulse-wave analysis assesses global endothelial function based on 
measures of systemic arterial stiffness (2).  Currently, FMD is the preferred method of examining 
endothelial function, over venous occlusion plethysmography or pulse-wave analysis, as it 
directly assesses conduit artery endothelial function and allows for repeated measurements (14). 
2.4: Existing Flow Mediated Dilation Protocols  
After conducting an extensive literature review (Appendix 5: Table 6) a limited number of 
articles using a distal occlusion protocol of the SFA and PA were found. Conversely, BA distal 
occlusions are commonly performed and a protocol was recommended by Corretti et al. (14). 
The International Artery Reactivity Task Force published Guidelines for the Ultrasound 
Assessment of Endothelial-Dependent Flow-Mediated Vasodilatation of the Brachial Artery(14); 
this article describes the equipment, images, protocol and analysis that need to be performed 
when examining FMD within the BA. With regards to equipment, Corretti et al. explain that the 
ultrasound must be able to acquire two-dimensional images, color and spectral Doppler, in 
addition to being equipped with an internal ECG monitor and a high-frequency vascular 
transducer. These researchers suggest that M-mode sweeps of longitudinal BA images should be 
used and they recommended against cross-sectional images because of inadequate wall definition 
(14).    
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The guidelines recommend that after collecting a baseline diameter and velocity reading, the 
pneumatic cuff should be inflated to a pressure at least 50mmHg greater than the participant’s 
systolic blood pressure for a “standard”, undetermined, length of time. Diameter should be 
recorded continuously from 30 seconds prior to deflation to two-minutes post deflation while RH 
blood flow velocity should be recorded immediately post deflation (14). There are many missing 
pieces in the guidelines such as: cuff placement, the usefulness and effects of exercise during 
occlusion, limb differences, and how the FMD response should be normalized. Other groups 
have subsequently investigated these issues because they have been found to alter the magnitude 
of the shear response, which can alter the EDRF secreted and the magnitude of FMD response. 
Regardless of the limitations to the Corretti paper, it has been referenced by over 1200 articles 
since its publication and in the current study was used to generate the various protocols.   
2.5: Nitric Oxide Mediated Flow Mediated Dilation  
As mentioned above, endothelial NO production is decreased in patients with CVD and other 
disease states; therefore, when performing an FMD experiment researchers want to ensure the 
dilation is NO mediated and thus can infer NO bio-availability. To determine if NO and/or 
prostacyclin mediated FMD in peripheral arteries L-NMMA, a NO synthase inhibitor, or 
Aspirin, a prostacyclin inhibitor, was given to the participants prior to conducting a FMD test 
(32; 44). Joannides et al. demonstrated that L-NMMA abolished RA FMD while having no effect 
on the peak hyperemia response. When Aspirin was administered no effects on reactive 
hyperemia or FMD were noted (32). Mullen et al. confirmed these findings after manipulating 
RA blood flow; they reported that L-NMMA almost completely abolished (FMD= 0.7+0.7%) 
RA FMD, while Aspirin had no significant impact of the magnitude of the FMD response (44). 
This led Joannides et al. and Mullen et al. to conclude that dilation post short-duration occlusions 
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are mediated by NO, not prostacyclin. These results hold true when the occlusion occurs distal, 
below, the site of measurement, but not when the occlusion is proximal, above the site of 
measurement (18).  
There are a number of conditions under which NO does not mediate the FMD response, 
including proximal cuff placement and prolonged shear stress. The effect of cuff placement, 
relative to the site of measurement, on which EDRF mediates the FMD response was examined 
by Doshi et al. (18). They wanted to determine which EDRF is responsible for BA FMD post 
five-minutes of occlusion at 250 mmHg when the cuff is distal (placed around the wrist) or 
proximal (placed around the upper arm). This was accomplished by examining the FMD 
responses with and without the administration of L-NMMA. Doshi et al. concluded that L-
NMMA infusion blocked the FMD response post distal occlusion of the BA but not post 
proximal occlusion; suggesting that FMD post distal occlusion is NO mediated and FMD post 
proximal occlusion is mediated by other EDRFs (18). Mullen et al. examined the effect of shear 
stress duration on the mediators of a FMD response. These researchers demonstrated that FMD 
responses post 15-minutes of occlusion are not solely mediated by NO as FMD was not 
attenuated with L-NMMA infusion (44).Therefore, FMD post five-minutes of distal occlusion is 
NO mediated (18; 32; 44) and can be used a measure of NO bioavailability and provide insight 
into a patient’s vascular and endothelial health. More research is needed to determine which 
EDRFs influence FMD post proximal occlusions and occlusions of greater than five-minutes as 
it is clear that these occlusions result in FMD responses that are not solely mediated by NO.  
Prior to 2008, NO-mediated FMD was only proven in the BA and RA. Due the heterogeneity of 
arm and leg vasculature, researchers needed to confirm these findings in leg conduit arteries such 
as the SFA or PA. Kooijman et al. performed distal occlusions of the SFA for five-minutes at 
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220 mmHg on eight healthy males (36). Continuous direct L-NMMA infusion into the SFA 
during occlusion and reactive hyperemia, at a similar dose to that used by Mullen et al., was used 
to inhibit NO mediated dilation. Percent FMD and FMD: SSAUC were significantly blunted with 
the infusion of L-NMMA thereby confirming that leg conduit arteries FMD due to short (<five-
minutes) duration occlusion is NO mediated.  
 Carlsson & Wennmalm found contradictory results using venous occlusion plethysmography 
(12). These researchers reported that forearm RH was significantly diminished when ibuprofen 
and/or naproxen, two cyclooxygenase inhibitors, were administered (12). This is an older study, 
in which a different technique was used; furthermore, no diameter changes were measured and 
no recent studies have confirmed these findings. Thus it can be concluded that for short duration 
(five minutes or less) distal occlusions, the FMD responses are primarily NO mediated in arm 
and leg conduit arteries.  
2.6: Shear Stress 
Shear stress is the primary mechanism mediating the increase in diameter post cuff deflation. 
To better understand shear stress a brief discussion on conduit artery blood flow is required. 
Arterial blood flows in a laminar fashion; therefore, velocity is greatest at the center of the artery 
and decreases as it approaches the arterial walls. In the laboratory, velocity can be measured 
using Doppler ultrasound and subsequent analysis allows vessel blood flow to be calculated 
using the following equation. 
Equation 2 (31):  
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Appropriate blood flow is essential for the supply of oxygen and nutrients to underlying tissue. 
Without altering mean blood flow velocity, average flow in one heart beat, blood flow can be 
modified via changes in arterial diameter (Equation 2).   
Under normal resting conditions, flowing blood exerts a frictional force on the blood vessels, 
which is termed shear stress (32). The magnitude of arterial MBV is an important factor in 
determining shear stress (Equation 3).  
Equation 3 (15):    
Shear stress is proportional to blood flow velocity while being inversely proportional to vessel 
diameter. The nature and magnitude of the shear stimulus has a direct impact on the FMD 
response (56). Pyke and Tschokovsky suggested that the rate of onset, magnitude, and duration 
of the shear stimulus affect the magnitude of a FMD response. The shear stress stimulus can be 
altered by occlusion duration, baseline diameter, the presence or absence of exercise, extremity, 
and concentrations of female sex hormones (56). Lastly, how the FMD data are normalized must 
be considered as it determines if a small FMD response is indicative of endothelial dysfunction 
or simply a small shear stimulus (56). Many of these issues were insufficiently examined by 
Corretti et al. (14) and must be further examined so that the results of future studies can more 




2.7: Factors Affecting the Elicited Shear Stimulus and FMD Response 
2.7.1: Shear Stress Duration 
As previously discussed, short and long duration shear stimuli are mediated by different 
mechanisms. This phenomenon can potentially be explained by the “sequential recruitment of 
mechanisms” hypothesis. This hypothesis postulates that at the onset of a shear stimulus NO is 
released and is the primary mediator of FMD. If, however, an elevated shear stimulus is 
maintained, then non NO-mediated FMD occurs; currently the mediating mechanisms and the 
timing of the shift from NO to non NO-mediated FMD are still not well understood.  Mullen et 
al. suggested that vasoactive prostanoids play a minimal role in vasodilation (44) and  it is 
possible that non-endothelial dependent pathways could be involved in FMD due to long 
duration shear stress.  
2.7.2: Baseline Diameter 
The baseline diameter of the artery being examined will have an impact on the magnitude of the 
shear stimulus.  Pyke & Tschokovsky reported that smaller conduit arteries show a larger FMD 
response to RH compared to larger arteries. They attributed this finding to the tendency for 
smaller conduit vessels to experience greater shear rates (Equation 3) (56). For example, 
Celermajer et al. reported that in healthy adults average baseline BA diameter is 0.37cm while 
SFA baseline diameter is 0.68 cm. Post four and one-half minutes of distal limb occlusion, BA 
FMD was 11% while the SFA FMD was 4% (13). Clearly there is a link between baseline 
diameter and the magnitude of the FMD; however, more research is still needed to better 




2.7.3: Cuff Placement 
As previously mentioned (Section 2.5) the location of the pneumatic cuff, proximal or distal to 
the measurement site, will affect the EDRF responsible for the FMD response. Furthermore, cuff 
placement will affect the magnitude and duration of a FMD response. To reiterate, a proximal 
occlusion involves placing and inflating the blood pressure cuff above the site of measurement; 
whereas, a distal occlusion involves placing the blood pressure cuff below the site of 
measurement.  
Using a proximal occlusion site may result in the artery under consideration becoming ischemic 
which would result in different/additional mechanisms governing the FMD response (18). Doshi 
et al. examined BA FMD post wrist (distal) and upper arm (proximal) occlusion and found that 
proximal occlusion produced a significantly larger FMD response (11.60% vs. 7.25%) although 
there was no significant difference in the peak blood flow stimulus post cuff release (18). The 
increased FMD, as seen with a proximal occlusion, could be a result of the synthesis and release 
of prostacyclin due to the hypoxic environment (1; 5). However, it is unclear if hypoxia occurs, 
as it is possible that there is enough oxygen in the trapped arterial blood to supply the underlying 
vascular smooth muscle for a five-minute occlusion. Another possibility is that a proximal 
occlusion causes a reduction in intra-arterial pressure, which would induce myogenic dilation 
(22) thereby altering the FMD response. Lastly, a proximal occlusion may result in a different 
shear stress stimulus than a distal occlusion thus altering NO release (6). Doshi et al. reported 
that FMD post proximal occlusions was only partially attenuated with the use of L-NMMA 
(11.62% vs. 7.51%), suggesting that proximal occlusions lead to the release of other EDRF in 
addition to NO (18).  The possibility of a hypoxic environment or involvement of myogenic 
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dilation is not present with the use of distal occlusion; therefore it is recommended that a distal 
occlusion be used to measure endothelial function and NO bioavailability (6; 14).   
2.7.4: Effect of Exercise on FMD 
Exercise may be used during limb occlusion to augment the shear stimulus and decrease the 
occlusion duration. The concern when using an exercise protocol is the possibility of sympathetic 
nervous system (SNS) activation.  The SNS is an important regulator of cardiovascular function 
(61) and patients with CVD have impaired FMD responses and increased sympathetic nerve 
activity (SNA) (13; 21). An increase in SNA in young healthy individuals might lead to a 
decrease in the magnitude of the FMD response. Dyson et al. demonstrated that only certain 
methods of elevating SNA result in an impaired FMD response (19). When SNA is elevated, 
mean arterial pressure (MAP) and reactive hyperemia responses are altered. For example, 
continuous plantar flexion exercise with both calves occluded, increased muscle chemoreflex 
activity, which in turn elevated SNA (19). If an exercise protocol is used in conjunction with 
limb occlusion it is possible that an increase in SNA would blunt the FMD response or lead to 
non NO-mediated dilation (19). To avoid this issue, MAP should be monitored to insure that it 
does not increase more than 20 mmHg, as that is a marker for SNA.  
Another concern of using exercise during an FMD protocol is that conducted vasodilatation 
may play a role in conduit artery RH and FMD. Conducted vasodilatation is when arteriolar 
vasodilatation at the site of metabolic demand is transmitted to other arteries via endothelial cell-
to-cell communication through their gap-junctions (62). Pyke et al. examined the effect of 
forearm exercise on BA FMD and determined that neither SNA nor conducted vasodilatation 
played a role in BA FMD (55). Therefore, the addition of exercise to a short duration occlusion 
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(ex: two-minutes) may be an effective method of increasing the RH and shear stress responses to 
more closely match those of slightly longer (five-minute) occlusion durations.  
2.7.5: Limb Differences  
It has been well established that endothelial dysfunction is a systemic event, with changes in 
vascular and endothelial health in peripheral arteries mirroring changes in coronary vascular and 
endothelial health. Recent research has demonstrated a higher incidence of atherosclerotic 
lesions in the SFA compared to the BA (43). Therefore, if researchers and clinicians want to 
obtain a complete picture of a patient’s overall vascular health the results and interpretations of 
leg conduit FMD responses are needed in conjunction of BA FMD data. There is significant 
heterogeneity between the upper and lower limb vasculature and research is ongoing to 
understand these differences and their usefulness as a predictor of overall cardiovascular health.  
Arm and leg conduit arteries have noticeably different baseline diameters; BA diameter is 
approximately 0.4 cm while the PA and SFA are greater than 0.6 cm in diameter. Furthermore, 
while standing human legs experience large hydrostatic and transmural forces, which are not 
seen in the arms. Rowell estimated that the lower limb experiences 65mmHg more pressure than 
the arms (59). The increased blood pressure (+65mmHg) experienced in the legs induces changes 
in endothelial function (72) and phenotypic changes to vascular smooth muscle cells (30). Hill et 
al. suggested that differences in receptor expression, receptor activation, structural proteins and 
signal transduction proteins might be partially responsible for limb differences in FMD (30). 
Nishiyama et al. documented greater vascular function in the PA (legs) than the BA (arms), 
where vascular function can be defined as the ability of an artery dilate in response to a 
controlled shear stimulus. They attributed this difference to either adaptive vascular stiffening in 
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the legs or differences in limb conduit artery muscle bed perfusion (48). Using MRI data, Wu et 
al. reported that BA shear rates are approximately 50% greater than those of SFA (80). Using 
Doppler ultrasound data, Newcomer et al. reported an approximate 40% increase in BA shear 
stress (46) as compared to the femoral artery. Furthermore, Newcomer et al. reported a smaller 
increase in blood flow and vascular conductance in the leg as compared to the arm (45). When 
examining the differences in conduit artery FMD, there is a trend that legs have a lower FMD 
response than the BA (69). It has been postulated that the lower shear rate, blood flow and 
vascular conductance in the leg may contribute to the significantly higher incidence of 
atherosclerotic lesions found in lower limb vasculature (43). This evidence further highlights the 
importance of studying leg conduit artery FMD.  
At rest and during exercise the legs require a higher absolute blood flow and percent cardiac 
output ( ) due to their greater muscle mass and subsequently larger blood and oxygen demands. 
However, when blood flow is normalized to limb volume, the arms appear to have greater blood 
flow than the legs (11). More research is needed to clarify this issue and understand how it 
impacts our understanding of limb differences and FMD responses.  
Regardless of the reason, arm and leg conduit arteries have different baseline diameter and 
blood flow and FMD responses. It is likely that the differences in shear stress are an important 
predictor in limb FMD differences. Leg conduit arteries are more susceptible to the development 
of atherosclerotic lesions than arm conduit arteries, which stress the importance of conducting 
and understanding leg FMD responses. More work is still needed to understand limb differences 
in FMD and how both arm and leg FMD responses can be used to gain a better and more 
comprehensive picture of a patient’s overall vascular health. 
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2.7.6: Superficial Femoral vs. Popliteal Artery for Assessment of Lower Limb FMD 
When assessing lower limb vascular function, researchers can examine either the PA or SFA. A 
review of the anatomy of the SFA and PA revealed that these arteries stem from the common 
femoral artery (CFA). The CFA originates in the femoral triangle and it receives blood from the 
external iliac artery. As the CFA descends the leg, it curves medially it branches into the deep 
artery of the thigh and the SFA. The SFA continues down the leg, dives deep and emerges 
behind the knee joint as the PA (79). MRI images of this artery, reveal no branching between the 
location where it is known as the SFA and where it is known as PA (79).  In the current literature 
review three experiments examined the PA, and six studied the SFA. These papers were 
reviewed as all occlusions were distal to site of measurement.  
Of the experiments where the PA was occluded, differences exist in how the participants were 
placed, the occlusion pressure and occlusion duration. Nishiyama et al. examined the PA, and 
required their participants to lie supine, on a gurney that was adapted to allow for access to the 
PA and performed a distal occlusion (pressure >250 mmHg for five-minute) (48). Conversely, 
Padilla et al. placed their subjects prone, and inflated the cuff to 220 mmHg for two-minutes 
(51). Thijssen et al. placed their subjects in the prone position, inflated the cuff to a pressure 
greater than 200 mmHg for five-minutes (69).  
When Celermajer et al. first described the SFA FMD protocol they used distal thigh occlusions 
at a pressure of 300 mmHg for four and one-half minutes (13). This cuff placement has been 
continued in more recent publications; however, differences in occlusion pressure have been 
used. For example, Walther et al. inflated a thigh cuff for five-minutes to unspecified 
suprasystolic pressure (73), Silber et al. examined the femoral artery at a pressure 20 mmHg 
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greater than SBP for five-minutes (64) and Kooijman et al. chose a pressure of 220 mmHg for 
five-minutes (36) (see all SFA occlusion protocols in Appendix 5:Table 6). The above-
mentioned studies have used different occlusion pressures and have reported a wide range of 
FMD values (between 2 and 6.9%) in healthy participants. The variety of protocols and the wide 
range of FMD values have made finding the optimal SFA FMD protocol difficult.  
The PA FMD protocols placed the blood pressure cuff around the subjects’ calf, whereas the 
SFA FMD has been studied using thigh cuffs. Wrapping the pneumatic cuff around the 
participant’s thigh causes greater participant discomfort than wrapping the cuff around the calf. 
Furthermore, by placing the cuff around the thigh, a larger amount of muscle is being occluded 
and therefore it is possible that more metabolites are being built up leading to greater 
downstream resistance vessel dilation and therefore a larger shear stress response. From a 
logistical standpoint, using the SFA may be simpler than using the PA due to its location on the 
front of the leg and measurement at a shallower depth. Using the SFA would allow participants 
to lie comfortably on their back and the shallower depth would allow for clearer ultrasound 
images. The improved image quality would improve wall detection and therefore diameter 





2.7.7: Time of Peak Diameter Measurement 
According the BA FMD guidelines, arterial diameter should be continuously recorded from 30 
seconds post deflation to two minutes post-deflation; however, this not always followed. 
Anderson et al. recommended that FMD be determined using diameter measures taken at 60 
seconds post deflation (3). The issue with using one single time point is that it may not capture 
the actual peak diameter, which has been reported to occur anywhere from 60 seconds to three 
minutes post deflation. Black et al. reported that FMD reported using diameter calculated at 60 
seconds post-deflation (FMD= 4.8%) was significantly lower than FMD reported using actual 
peak diameter (FMD= 7.3%) (7). This data further strengthens the recommendations of Corretti 
et al. that diameter needs to be continuously reported until two minutes post-deflation.  
2.7.8.: Additional Factors that can Affect FMD  
Other factors that need to be taken into consideration when conducting an FMD test are 
ambient temperature, recent exercise and alcohol and/or caffeine consumption. These factors 
have a reported vasoactive effect which can influence the magnitude of the FMD response (14).  
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2.7.9: Normalizing an FMD Response 
 
The magnitude of a shear stress stimulus created with the RH response directly affects the 
magnitude of the FMD response and has implications for interpretations of vascular health. As 
discussed above, the magnitude of the shear stimulus is affected by many factors including, but 
not limited to, sex, cuff placement and occlusion duration. Furthermore, RH blood flow peaks 
and decays before peak diameter is seen; therefore, a quantification that can appropriately 
describe the stimulus is integral for understanding an FMD response. This will allow researchers 
to determine if the small percent FMD is due to a small shear stimulus or to an endothelial 
dysfunction.  
Researchers are unable to agree on how best to normalize an FMD response. Currently, a FMD 
response may be normalized to the mean shear stimulus, peak shear stimulus and/or stimulus 
duration. Pyke and Tschakovsky and Padilla et al. suggested that shear stress area under the 
curve (SSAUC) provides the most reliable interpretation of endothelial function from an FMD 
study (50; 57). Pyke & Tschakovsky found that when only exposed to peak shear, a small 
increase in diameter was seen. Conversely, when a conduit artery was exposed to more than 30 
seconds of RH, a larger FMD response was observed. Therefore, Pyke & Tschakovsky 
recommended against normalizing the FMD response to peak shear and recommend normalizing 
to the total SSAUC (57).  
In a review article Pyke & Tschakovsky, argued that measuring shear stress and subsequently 
calculating SSAUC until peak diameter is achieved is the ideal method of quantifying the total 
stimulus that contributes to the FMD response(53). To achieve this, an ultrasound machine must 
be capable of recording flow and diameter simultaneously. These machines are more expensive 
than those that measure one or the other. This fact might contribute to why few studies normalize 
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their data to total SSAUC. Therefore, Pyke et al. recommended that both the peak shear stress and 
SSAUC until peak diameter should be recorded and reported when reporting a FMD response (54).  
2.8: Measuring Arterial Diameter 
The majority of research using FMD has chosen to image the conduit artery in the longitudinal 
plane. This orientation was chosen because it allows for clear definition of the artery-lumen 
boundary on the near and far wall (14). Kao et al. demonstrated that imaging in the longitudinal 
plane is associated with decreased sensitivity and accuracy in determining arterial diameter. 
They illustrate that a 10-20% increase in diameter for an artery with a baseline diameter of 0.5 
cm corresponds to a change of 0.5-1.0 mm. This significant change in diameter corresponds to a 
difference of a few pixels on an ultrasound image; therefore a sensitivity of greater than two to 
three pixels is needed in order to see a significant change in diameter (33). These changes can 
easily be masked due to slight movement of the transducer or the artery during deflation. 
Another limitation of using longitudinal images is that deviations in an artery from its traditional 
circular geometry may affect diameter measurements (33).  
The above-mentioned limitations of using longitudinal plane images to determine arterial 
diameter are not present when using transverse/cross-sectional views of a conduit artery. Recent 
advances in ultrasound technology, including improved spatial resolution and lateral wall 
definition, have made cross-sectional imaging a possibility. Kao et al. captured cross-sectional 
images of the BA and were able to outline the arterial boundaries (33). They reported that using 
cross-sectional images, compared to longitudinal images, allows for increased pixel resolution 
and thus improving the accuracy of detecting the peak diameter increase post cuff deflation 
(33). Furthermore, imaging in the transverse plane allows the entire cross-sectional area of the 
artery to be visualized; allowing the researchers to insure that the ultrasound probe is in the 
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correct place at all times during testing. The usefulness of determining arterial diameter in the 
transverse plane was validated by Stroz & Fenster (66). They reported that artery diameter 
determined via cross sectional imaging is not significantly different from arterial diameter from 
longitudinal images.  Furthermore, they reported that cross sectional diameter measurements are 
reproducible and that wall definition was not an issue. The above study used three-dimensional 
images, which is a feature not available on all ultrasound machines. More research using both 
two-dimensional and three-dimensional transverse images in FMD studies is required to 
validate the use of two-dimensional transverse imaging.  
Wikstrand determined that vessel diameter should be calculated by measuring the distance 
between the leading edge of the intima-lumen echo on the near wall to that of the far wall. 
However, ultrasound visualization of the near wall intima-lumen surface is unreliable and thus 
the lumen-media echo is often used in its place (77) (Figure 2).  
 
Figure 2: Schematic of the correlation between the anatomical structures and echoes generated 
images produced by the ultrasound to the carotid artery (77) 
 
Currently when measuring arterial diameter to analyze FMD data the above-mentioned method 
is used (14). However, measuring arterial diameter from different structures on the near and far 
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wall is illogical. Furthermore, since defining the near wall structures is difficult, the issue of 
reliability and reproducibility using this method must be considered. In the current experiment, 
arterial diameter measurements were performed using both the current standard edge-detection 
method and using a new measurement method called the center-based method. The center-based 
method measures arterial diameter as the distance between the center of the wall (media layer) 
on the near to that on the far wall.  
2.9: Hypothesis Generation 
 
Endothelial cells play an integral role in the regulation of vascular tone. In response to short 
duration (< five-minute) occlusions, NO is released by EC’s and directs vascular smooth muscle 
cells to dilate. Currently limited standardization of the FMD protocol, especially when testing the 
lower limb, limits our understanding of arm and leg conduit artery FMD and how it correlates to 
overall cardiovascular health. 
To gain a better understanding of the possibilities and limitations of using lower limb FMD two 
large lower limb conduit arteries, SFA and PA, were examined.  The SFA and PA were 
subjected to five-minutes of occlusion with no exercise. The first goal of the current study is to 
determine if the SFA can be used instead of the PA when measuring leg conduit artery function. 
The location and depth of the SFA make it the preferential leg conduit artery to examine. A five-
minute occlusion at 220 mmHg was chosen as it follows the current guidelines used for BA 
FMD. It is hypothesized that there will be no significant difference in the shear stress, reactive 
hyperemia and FMD responses of the SFA and PA due to five-minutes of calf occlusion.  
A two–minute occlusion protocol was examined because reducing the occlusion duration will 
not only decrease testing time but also eliminate excess discomfort to the participant. The SFA 
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and PA were subjected to a two-minute occlusion with one-minute of exercise imbedded within 
it. A shorter duration occlusion will result in a smaller shear stimulus; therefore, exercise was 
added in order to increase the elicited shear stimulus. The “traditional” five-minute occlusion of 
the SFA and PA were compared to the two-minute with one minute of exercise protocol. The 
resulting shear stress and FMD responses were compared to determine the usefulness of the 
shorter occlusion protocol. It is hypothesized that a two-minute occlusion containing one-minute 
of exercise will produce the same shear stress and FMD response as the five-minute protocol in 
the SFA and in the PA.  Furthermore, the FMD and shear stress responses of the PA and SFA 
due to two-minutes of occlusion will not be significantly different.  
The heterogeneity between arm and leg vasculature may be an important factor in the location 
and development of atherosclerotic lesions. Performing leg conduit artery FMD protocols allows 
for exercise-mediated changes to the trained area to be seen. To gain a better understanding of 
arm and leg conduit artery differences a five-minute occlusion was performed on the BA, SFA 
and PA. It is hypothesized that the BA will have a significantly larger shear stress, reactive 
hyperemia and percent FMD response than the SFA and PA.  
Based on pilot data analysis, significant limitations to the current method used to measure 
arterial diameter, edge-detection method, were found including the fact that diameter is not 
measured between the same location on the top and bottom arterial wall. A new method of 
measuring diameter was created based on the premise of measuring diameter between the same 
location on the near and far arterial wall. The center-based method measures arterial diameter as 
the distance between the center of the media layer on the near wall to the center of the media 
layer on the far wall. The use of this method in determining BA FMD after five-minutes of 
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occlusion was explored. It is hypothesized that the center-based method will demonstrate the 




Chapter 3: Methods 
3.1: Participants 
Men, ages 18 to 35, with no current or familial history of clotting disorders, cardiovascular or 
respiratory diseases were recruited for this study. Participants were non-smokers not currently 
taking any medications. A health status survey was filled out by all participants prior to testing to 
screen for eligibility.  
Participants were required to abstain from caffeine, alcohol and exercise for 12 hours prior to 
testing. To confirm adherence, participants were asked by the examiners prior to beginning 
testing when and what their last meal was, the last time they drank caffeine and/or alcohol and 
last time they performed exercise.  If the participant did not adhere to the above-mentioned 
restrictions, the FMD testing was rescheduled. All trials were performed in a quiet, dark, 
temperature controlled room (21-24°C). Prior to beginning the test, written informed consent 
was obtained from all participants. This study protocol was reviewed and approved by the 




3.2: Experimental design 
Healthy young men who met the criteria specified in the “Participant” section were recruited for 
this study (Chapter 3.1). Potential participants were invited to visit the lab to fill out a medical 
screening form to filter out ineligible participants and to participate in a familiarization session. 
In addition, potential participants were given an information letter, approved by the ORE 
(#16079) to provide a better understanding of the current study and its potential risks.  
Participants were randomly assigned to either Treatment 1 (Table 1) or Treatment 2 (Table 2). 
Table 3 lists the limb (right vs. left) associated with the five and two-minute occlusions for 
treatment group 1 and 2. Care was taken to ensure that testing began at approximately the same 
time on each day of testing. Testing days were separated by at least 24 hours.  
When a participant arrived in the lab, his height, weight and previous meal were recorded. 
Participants were then connected to the electrocardiogram, Finometer
TM
, and had two manual BP 
measurements taken. If a participant was in the “Treatment 1” group, they were asked to lie 
supine and three FMD protocols were performed on their first visit to the lab. On their second 
visit, two PA FMD protocols were performed during which they were asked to lie prone (Table 
1). Conversely, if a participant was in “Treatment 2”, they were instructed to lie prone and 
underwent two PA FMD protocols on their first visit to the lab. On their second visit they were 
asked to lie supine and a BA and two SFA FMD protocols were performed (Table 2). If a 
participant agreed to take part in the reproducibility study, they were required to return to the lab 
for a third day of testing (see chapter 4.0:“Reproducibility Study”).   
In between each FMD protocol, a ten to fifteen minute break was given; this allowed the 
participant time to rest and provided time for the researchers to set up for the next test. Due to the 
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fact that the FMD protocols were being performed on different limbs (right arm and the right and 
left legs) there was no concern of a carry-over effect from the previous FMD protocol. 
Furthermore, on all testing days, the exercise FMD protocol containing one-minute of exercise 
was performed last to avoid any carry-over effects of exercise on arterial dilatory responses.   
Table 1: Testing Protocol 1 














































Testing Day 2 
Five minute BA FMD 
 
Five-minute PA FMD 
 
Ten to fifteen 
minute break 
Set up 
SFA FMD  
Ten to fifteen 
minute break 
Set up PA 
FMD on 
other leg 
Five-minute SFA FMD Two-minute PA FMD with one 
minute of exercise 







Two-minute SFA FMD with 
one-minute of exercise  
 
Table 2: Testing protocol 2 














































Testing Day 2 
Five minute PA FMD 
 
Five-minute R-BA FMD 
 
Ten to fifteen 
minute break 
Set up PA 
FMD on 
other leg 
Ten to fifteen 
minute break 
Set up SFA 
FMD 
Two-minute with one-minute 
of exercise PA FMD 
Five-minute SFA FMD 
 Ten to fifteen 
minute break 
Set up SFA 
FMD on other 
leg 
Two-minute with one-minute of 





Table 3: Randomization of occlusion protocols 
 Treatment 1 group Treatment 2 group 
 S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 
Tests           
R-BA x x x x x x x x x x 
R-POP5      x x x x x 
L-POP2      x x x x x 
L-SFA5      x x x x x 
R-SFA2      x x x x x 
L-POP5 x x x x x      
R-POP2 x x x x x      
R-SFA5 x x x x x      
L-SFA2 x x x x x      
Reproducibility           
RBA      x x x x x 
LSFA5      x x x x x 
RPOP5      x x x x x 
Abbreviations: L=left, R=right, SFA= superficial femoral artery, PA= popliteal artery, BA= brachial artery 




3.3: Flow-Mediated Dilation Protocol 
Endothelial vasomotor function of the BA, SFA and PA was assessed using FMD. The current 
protocol design was based on data acquisition and analysis by Celermajer et al. (13)and Corretti 
et al. (14). All occlusions performed in the current study were distal to the site of MBV and 
diameter measurements. The BP cuff was wrapped either around the forearm, just below the 
elbow, or around the lower leg, just below the knee joint. Once the cuff was in place but before 
inflation, one minute of baseline flow velocity and baseline arterial diameter were collected.  
After one minute of baseline, the cuff was inflated to 220 mmHg for either two or five minutes. 
The five-minute protocol did not contain an exercise component and the participants were 
instructed to remain still and avoid any leg or arm movements. The two-minute protocol 
contained one-minute of exercise; the subjects were instructed to press on a footplate until the 
sphygmomanometer reads plus 100 mmHg of their baseline pressure value.  
After the allocated occlusion duration, the cuff was rapidly deflated. During the first 30 seconds 
post deflation, continuous MBV was recorded. Every 15 seconds from 45 seconds to 2.5 minutes 
post deflation, arterial diameter was determined (Figure 3 & 4). 
 




Figure 4: Two-minute with exercise FMD protocol for the SFA and PA 
3.4: Physiological Measures 
3.4.1: Cardiac Measures   
Heart rate (HR) was measured via an electrocardiogram (Colin Pilot, San Antonio, Texas) by 
placing three electrodes on the participant. When the participant was in a supine position three 
electrodes were placed as follows; one below the right clavicle (negative lead), a second below 
the left clavicle (grounding lead) and a third on the left 12
th
 rib (positive lead). When the 
participant was in the prone position, three electrodes were placed on their back as follows: one 
just above the spine of the right scapula (negative lead), a second just above the spine of the left 
scapula (grounding lead) and a third on the left 12
th
 rib. The “R” peak from each heartbeat was 
used for beat-to-beat analysis of all the physiological variables.  
Blood pressure (BP) and cardiac output ( ) were estimated using an infrared 
photoplethysmographic cuff (Finometer, Finapres Medical Systems, Arnhem, Netherlands) 
placed on the participant’s middle finger.  The finger cuff detects small changes in arterial 
diameter and controls cuff pressure to oppose changes in arterial pressure. The Finometer
TM
 uses 
the volume-clamp method of Penaz and the Physiocal criteria of Wesseling to continuously 
measure finger arterial pressure. Modelflow technology was employed to continuously estimate 
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 from finger BP using a non-linear, self-adaptive model of aortic impedance (76). The non-
linear equation used by the Finometer
TM
 software employs a three-element (aortic impedance, 
Windkessel compliance and peripheral resistance) non-linear equation, which is dependent on 
the aortic pressure-area relationship. Finger arterial pressure was corrected to brachial BP using a 
return-to-flow (RTF) calibration. The RTF calibration was achieved by inflating the Finometer
TM
 
arm BP cuff to suprasystolic pressures and determining when the first pulsations pass under the 
cuff and are detected by the finger cuff. A height corrector was used by the Finometer
TM
 to 
compensate for the finger not being at heart level. The Finometer
TM
 accurately measures beat-to-
beat variations in BP within the Association for the Advancement of Medical Instrumentation 
standards. To further ensure the accuracy of the Finometer
TM
, two manual BP measurements 
were taken prior to the beginning of testing on each day of testing. If the Finometer
TM
 reported a 
BP value that differed from the manual measurements by more than 15 mmHg, the Finometer
TM
 
BP data were corrected to match manual reading. This was accomplished by adjusting the 
Finometer
TM
 BP data once it had been exported to excel to align it with the manual BP data.  
3.4.2: Measuring Arterial Diameter and Blood Flow Velocity 
Mean blood flow velocity (MBV) of the SFA, PA and BA was continuously measured by 
placing a 4 MHz Doppler probe (Multigon 500M, Mt. Vernon, New York) over the artery under 
consideration. The 4 MHz Doppler ultrasound probe directs its signal at a 45° angle relative to 
the skin. Arterial blood flow velocity was recorded using a computer via data acquisition 
software (Chart 5 and Powerlab, ADInstruments, Colorado). Artery specific mean blood flow 
(MBF) was calculated using the following equation: 
Equation 4:  
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This equation demonstrates how vessel diameter is an important determinant of flow. To allow 
for MBF comparisons between participants, MBF was adjusted to the participant’s limb volume, 
per 100 ml of tissue using the following equation. 
Equation 5:    
Arterial diameter was measured using a 15 to 6 MHz Doppler ultrasound linear array probe 
(Sonosite Micromaxx
TM
, Bothell, Washington); cross-sectional arterial M-mode sweeps were 
used to capture arterial images. This method was chosen, contrary to the recommendations of 
Corretti et al., who recommended longitudinal B-mode images be used to measure diameter 
because pilot data demonstrated improved image resolution when images were captured in the 
transverse plane.  
The use of cross-sectional and M-mode imaging has recently been validated. The use of M-
mode over B-mode sweeps was substantiated by Kelly et al. (34). These researchers 
demonstrated, via a Bland-Altman analysis, a strong agreement between M-mode and B-mode 
diameter and FMD measures (34). Furthermore, Kelly et al. reported higher image resolution 
with M-mode as compared to B-mode images (34). The use of cross-sectional US images to 
determine artery diameter has recently gained support by Stroz & Fenster (66) and Kao et al. 
(33).  
Ultrasound video was recorded to either a S-VHS videotape or captured directly to a computer 
using a video capture card. After testing, the video was uploaded to the computer and still images 
were taken at the desired time points. From these images end-diastolic diameter was calculated 
and analyzed using the program MATLAB.   
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3.4.3: Limb Volume 
Forearm and lower leg volume was measured using water displacement. Forearm volume was 
measured from the base of the olecranon process to the head of the ulna. The participant was 
asked to submerge his arm, up to the olecranon, providing a volume for the arm and hand. 
Subsequently, his hand was submerged, up to the head of the ulna, and this volume was 
subtracted from the arm and hand volume to obtain forearm volume.   
Lower leg volume was measured from the base of the medial malleolus to the top of the medial 
epicondyle. The participant was asked to submerge his leg up to the medial epicondyle and a 
volume for the leg and foot was obtained. Subsequently foot volume, up to the medial malleolus, 
was obtained and subtracted from the leg and foot volume to obtain leg volume.  
3.5: Data analysis 
The internal diameters of the three arteries were measured at rest and every 15 seconds from 45 
seconds to 2.5 minutes post cuff deflation. All arterial diameters were measured at end-diastole, 
as it has been suggested that during systole the increase in pressure and volume produces an 
approximately 5% increase in reported artery diameter (17; 24).  
After testing, a subject’s ultrasound video was uploaded to a computer allowing still images of 
baseline and post deflation diameter to be captured and analyzed. The standard method of 
determining arterial diameter is via edge-detection. This involves determining the distance 
between the intima-lumen edge of the near wall and the intima-lumen edge of the far wall (Ch 
2.8, Figure 2). As previously discussed, limitations with ultrasound technology make detection of 
the near wall intima layer indistinguishable from the adjacent media layer; therefore arterial 
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diameter is measured as the distance between the media-lumen edge on the near wall and the 
initma-lumen edge on the far wall (77).  
Currently our lab measures arterial diameter using a MATLAB edge detection script called 
GDM. Pilot data analysis revealed many limitations with this software including trouble with 
reproducibility and inaccurate tracings of the edge of the top and bottom arterial walls. When 
edge-detection was performed using GDM manual corrections were needed to insure that the 
correct structures on the near and far arteries walls were being identified and used to calculate 
arterial diameter. Manual detection of arterial walls and thus arterial diameter is subject to 
significant experimental/observer error (78). Conversely, “computer-assisted” analysis would 
eliminate the above-mentioned source of error and has been shown to increase the precision of 
diameter and FMD measurements (78).  
Based on the work of Woodman et al. and the pilot data analysis performed in the current study, 
two new “computer-assisted” MATLAB scripts written by Aaron Katz called the centre-based 
method and the edge-detection method were used to measure arterial diameter in this study.  
Prior to image analysis, the image under consideration will be “cleaned- up” using a standard 
pre-processing filter to smooth the image with a Gaussian kernel to reduce noise in the data and 




3.5.1: Centre-Based Method 
The centre-based method calculates the numerical integral across each column of pixels, for a 
user-selected section of the image. The software then determines the location where the 
integrated intensity is half the total intensity, the point where one half of the intensity lies on 
either side of the program-generated line. This method was chosen as the resolution of the 
ultrasound system (US) (ignoring other parts of the system such as the image acquisition or 
digitization systems) is on the same order as the thickness of the wall (US: ~0.5-1.5mm, wall 
~0.4-1mm) (10). Due to this correlation, wall substructures (intima, media and adventia) are 
difficult to distinguish without specific knowledge of the entire image generating system. 
Detection of the media wall can be difficult; therefore, based on the assumption that the 
response of the ultrasound is primarily due to the media rather than the intima or adventia (due 
to the low acoustic backscattering in these regions), the centre of the wall can be used instead. 
This method defines the centre of the wall not as the peak intensity but as the point at which half 
the density of tissue (taken to be equivalent to intensity) is located on either side (Figure 5). 
 
Figure 5: Crop of an M-mode sweep of a male superficial femoral artery whose diameter has 




3.5.2: Edge-detection Method 
This method is based on the definition of an edge as the maximum gradient of the intensity for 
the selected cropped image. To overcome the problem described above with ultrasound 
resolution, the gradient is weighted by the original intensity value (Katz, 2010). This effectively 
shifts the edge towards the high intensity section of the band, which matches the physiological 
structure that forms the image. The image undergoes a modification of a second order method; 
the media edge of the near wall is defined as second zero derivative and the intima edge of the 
far wall is found using the peak of the second derivative. Mathematically, the zero crossing for a 
second derivative is the same as the peak of a first derivative; however, due to the noise and 
granularity of the data it can be difficult to accurately identify the peak of the derivative. By 
assuming certain details of the shape of the data combined with smoothing using a Gaussian 
kernel, an estimate of the second derivative can provide an accurate sub-pixel position for an 
actual edge. This method differs from the “standard method” because the derivative is weighted 
by the intensity before the second derivative is taken (Figure 6 & 7). The major benefit of this 
edge-detection script over GDM is that manual corrections were not needed to accurately trace 










Figure 7: Crop of an M-mode sweep of a male superficial femoral artery whose diameter has 
been determined using the edge-detection method 
 
Based on the diameters determined from the two methods described above, percent FMD will 
be determined by Equation 1(chapter 2.3). All reported diameter values are an average of two to 
three cardiac cycle end-diastolic diameters.  Maximal arterial diameter post deflation, maximum 
FMD, will be determined using Equation 1, where Dpost will be the largest recorded diameter 
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post deflation. Maximal FMD will be normalized to the elicited shear stimulus by calculating the 
ratio of percent FMD to SSAUC.  
Research has suggested that a BA FMD response of less than 4% is an indicator of endothelial 
dysfunction and reduced NO bioavailability (58). As young healthy males were examined in the 
current study a FMD of less than 4% was interpreted as the eliciting shear stimulus was unable to 
generate a FMD response. Therefore, the occlusion protocol was unable to elicit a strong enough 
shear stimulus to cause a significant increase in arterial diameter post cuff deflation.  
3.5.3: Analysis of Hemodynamic Variables  
Beat-to-beat analysis of systolic blood pressure, diastolic blood pressure, mean arterial pressure 
(MAP), cardiac output (Q) and heart rate (HR) were performed at rest and until two and one-half 
minutes post deflation. During the first 30 seconds post deflation MBF, vascular resistance (VR), 
conductance (VC) and shear stress ( ) were calculated using Equations 4-8.  
Equation 4:  
 
Equation 6:  
Equation 7:  
Equation 8:  
The shear stress area under the curve (SSAUC) was calculated for the first 20 seconds post 
deflation. To better compare the participants’ SSAUC, the beat-by-beat data were converted into 
per second data.  
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3.6: Statistical analysis 
Statistical Analysis Software (SAS Institute, Cary NC, USA) was used for all statistical 
procedures.  Comparison of baseline diameter, shear stress, vascular resistance and vascular 
conductance was performed via a one-way ANOVA and subsequent Tukey Post Hock test. The 
effect of the five- and two-minute occlusion protocols on the SFA and PA were examined using 
a paired t-test (SFA5, SFA2, PA5 and PA2 respectively). The differences between baseline 
diameters, peak diameters, percent FMD, SSAUC and FMD:SSAUC were examined. The SFA5 
condition was compared with the PA5 and SFA2 conditions and the PA5 was compared to the 
PA2 condition. A Bonferoni correction was used to correct for the use of the same parameter in 
multiple comparisons; therefore, α=0.05/4, resulted in a significance level of p<0.0125 being 
used to determine significance.  
The effect of artery size and location was examined by comparing the FMD and SSAUC data 
from five-minute distal occlusions on BA, SFA and PA using a one way ANOVA. Percent FMD 
and SSAUC values for the BA, SFA, PA were compared at a significance level of p<0.05. 
Significant differences were noted, therefore a Tukey Post Hoc test was used to uncover which 
arteries, FMD and shear stress values were significantly different from one another.  The effect 
of baseline arterial diameter on FMD and SSAUC of the BA, SFA and PA were examined via a 
correlation analysis.  
To compare the center and edge detection methods of determining artery diameter a one-way 
ANOVA of FMD and time to FMD was used. A significance level of p<0.05 was used. The BA 
was used for this analysis since the greatest body of literature exists concerning the expected 
range of FMD values and the underlying mechanisms responsible for these changes in diameter.  
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Chapter 4: Reproducibility Study 
 
4.1: Reproducibility Study Methods 
Five participants (S6-S10) were asked to participate in a reproducibility study. The participants 
came to the lab for one additional day of testing.  On this day, three FMD protocols were 
performed: a five-minute BA FMD, a five-minute L-SFA FMD and a five-minute R-PA FMD 
(Table 4). The lower limb FMD protocols were performed on the same limb using the same 
procedure as on day one and day two.   
Table 4: Reproducibility study protocol  
Testing day 3 
Five-minute BA FMD 
-Using right arm 
Ten-fifteen minute break Set up L-SFA FMD 
Five-minute L-SFA FMD 
Ten-fifteen minute break Set up R-SFA FMD 
Two-minute with exercise R-SFA FMD 
 
Correlation analysis was run on baseline diameter, peak diameter, time-to-peak-diameter, peak 
shear stress, SSAUC, and FMD. A correlation value, r, of greater than 0.90 was used to determine 
if the values were statistically similar between the different testing days. It should be noted that 
correlation analysis on calculated variables, such as FMD, peak shear stress or SSAUC, is difficult 
as the differences in each of the variables is multiplied in the calculation of the desired value. For 
this reason, greater importance will be placed on direct measurements such as baseline diameter 
and peak diameter. Reproducibility was determined using both the Bland-Altman analysis and 
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correlation analysis. These tests examined baseline diameter, peak diameter, FMD, and shear 
stress area under the curve (SSAUC) for the five-minute BA, SFA and PA FMD protocols.  
4.2: Reproducibility Study Results 
A correlation analysis revealed that PA baseline diameter, time to peak diameter and peak 
diameters were reproducible (r=0.981, 1.00 and 0.979 respectively) between testing day 1 and 3. 
A correlation analysis of the BA revealed that baseline diameter, peak diameter and time to peak 
shear were reproducible between testing day 2 and 3 (r= 0.971, 0.929 and 0.902 respectively). 
The SFA correlation analysis revealed that only baseline diameter and peak diameter (r=0.997 
and 0.992 respectively). SSAUC, and FMD were not reproducible in the SFA, BA or POP. Since 
peak shear and SSAUC were not strongly correlated between testing days, it appears that it is 
difficult to elicit a similar shear stimulus on different testing days. (For more information refer to 
Appendix 6: Table 7) 
The reproducibility of baseline and peak diameter of the BA, SFA and PA can be seen in the 




4.3: Reproducibility Study Discussion 
The results of the reproducibility study demonstrate that the diameter values reported in the 
current experiment are an accurate representation of changes occurring in the BA, SFA and/or 
PA after different occlusion conditions. The reproducibility data demonstrate that baseline and 
peak diameters are reproducible in all three conduit arteries on different testing days.  
The strong correlation of BA, SFA and PA peak diameters that was seen between both days of 
testing was not expected since SSAUC and FMD were not correlated between the two testing 
days. The data emphasizes that a five-minute occlusion performed on different days can illicit 
different shear stimuli but produce similar peak diameters. The similarity of peak diameter 
values due to significantly different shear stimuli can be explained by the fact that the 
participants in this study were young healthy males and therefore even with a significantly lower 
shear stimulus near maximal vasodilatation was able to occur.  
The lack of correlation in shear stress between testing days could be due to the uncontrolled 
nature of eliciting a shear stimulus (53). The magnitude of a shear stimulus, post temporary limb 
ischemia, is due in part of the magnitude of alterations down-stream vascular resistance and 
baseline conduit artery diameter. Pyke et al. suggested that the uncontrolled nature of the shear 
stimulus limits one’s ability to reproduce a shear stimulus (53). Woodman et al. demonstrated 
that percent FMD was reproducible between visits, however shear stress data were not shown 
thus making any conclusions about shear stress reproducibility impossible (78). The above-
mentioned research in conjunction with data obtained from the current study suggested that in 
young healthy individual’s peak diameter was reproducible between visits; however, the eliciting 
shear stimulus was not consistently reproducible between visits.  
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The current study demonstrated that peak diameter was reproducible however FMD was not. It 
is likely that the lack of FMD correlation between testing days seen in the current study is due to 
mathematical limitations. There were small differences in both the baseline and peak diameter 
measurements. As a result when FMD was calculated and a correlation analysis was performed, 
those differences were magnified, creating a weaker correlation.  FMD was examined both as a 
percent and as a ratio to SSAUC. For the above-mentioned reasons, the ratio of FMD to SSAUC 
was not put through a correlation analysis. Examination of the data revealed noticeable 
differences in FMD:SSAUC (Appendix 6: Table 7)between testing days in the BA, SFA and PA 
for all participants. These results emphasize that the FMD response produced is a result of the 
elicited shear stimulus, produced after five-minutes of distal occlusion.  
Taken together the results from the reproducibility study demonstrate that experimenter 
performed measures, such as diameter measurements, are reproducible. Limitations in 
reproducibility appear to lie in statistical limitations with calculated variables and not in 
procedural practices or experimental setup. Therefore the FMD and SSAUC values obtained in the 
current study are an accurate measure of changes in conduit artery diameter due to increased 




Chapter 5: Results 
5.1: Participant Characteristics 
Participants were young, normo-tensive (resting BP<140/90 mmHg), active men with a mean 
age of 27  4 years (range: 22 to 35 years, n=10).  All participants were physically fit reporting 
an exercise frequency of three or more times per week. Average height was 182 7 cm and 
average weight was 83 12 kg. The average forearm volume was 1000+81 ml and average lower 
leg volume was 2379 763 ml, (Appendix 1: Table 1). Resting BP and HR were taken prior to 
testing day 1 and 2 after the subject was lying supine for approximately 20 minutes. Average 
resting SBP was 120 5 mmHg, resting DBP was 68 5 mmHg and average resting heart rate 
was 61  11 bpm (Appendix 1: Table 1).  
5.2: Cardiovascular Data 
HR, BP and  were recorded throughout the entire duration of testing. There were no 
biologically significant changes in BP, HR or between baseline, occlusion, and deflation for 
any participant in any of the arteries examined (Figures 8a & 8b). Furthermore, one-minute of 
exercise during occlusion, did not result in an increase in blood pressure of more than 20 mmHg 





















































exerc ise D eflation and reactiv e hyperem ia
 
Figure 8a: A single participant’s heart rate in beats per minute throughout the superficial 
femoral artery two-minute occlusion with one-minute of exercise protocol 
T ime (sec)
























































exerc ise defla tion and ractiv e hyperem ia
occlusion
 
Figure 8b: A single participant’s mean arterial pressure, systolic blood pressure and diastolic blood 




5.3:  Arterial Baseline Parameters  
A one way ANOVA and subsequent Tukey’s test revealed that baseline BA diameter, 
conductance and shear stress were significantly different than baseline parameters of  the PA and 
SFA (p<0.05). In fact, baseline BA shear stress was between three and one-half and four and 
one-half times larger than baseline SFA2, SFA5, PA2 or PA5 shear stress (Figure 9). BA 
vascular conductance was significantly higher than that of the SFA2, SFA5 and PA5; however, 
no significant difference was found between the BA and PA2. This could be due to the smaller 
sample size (n=8) in the PA2 condition as compared with the BA, where all 10 participants data 
could be analyzed (Figure 10). Vascular resistance was not significantly different between the 
three arteries examined. There was, however, a trend for slightly lower BA vascular resistance 
compared to the SFA2, SFA5, PA2 and PA5 conditions (Figure 11). Baseline diameter of the BA 
was significantly smaller than the SFA and PA. The BA was approximately 0.25 cm smaller than 
the two leg conduit arteries examined (Figure 12). Baseline BA diameter was 0.42 0.05cm, 
while average SFA5 artery diameter was 0.67 0.08cm, SFA2 was 0.69 0.09cm, PA5 diameter 
was 0.661 0.09cm and PA2 diameter was 0.66  0.09cm. There were no significant differences 

























Figure 9: Average baseline shear stress in the brachial, superficial femoral and popliteal artery. 
Values are means + standard deviation. * indicates significantly different than SFA2, SFA5, PA2 
and PA5. Abbreviations: SFA5: superficial femoral artery five-minute occlusion, SFA2: superficial femoral artery 
two-minute occlusion, PA5: popliteal artery five-minute occlusion, PA2: popliteal artery two-minute occlusion 
Artery






































Figure 10: Average baseline vascular conductance of the brachial, superficial femoral and 
popliteal arteries before each occlusion protocol. Values are means + standard deviation. * 
indicates significantly different than SFA2, SFA5, PA2 and PA5. Abbreviations: SFA5: superficial 
femoral artery five-minute occlusion, SFA2: superficial femoral artery two-minute occlusion, PA5: popliteal artery 



































Figure 11: Average baseline vascular resistance of the brachial, superficial femoral and 
popliteal arteries before each occlusion protocol. Values are means + standard deviation. 
Abbreviations: SFA5: superficial femoral artery five-minute occlusion, SFA2: superficial femoral artery two-minute 
occlusion, PA5: popliteal artery five-minute occlusion, PA2: popliteal artery two-minute occlusion. 
Artery

























Figure 12: Average baseline diameter of the brachial, superficial femoral and popliteal arteries 
before each occlusion protocol. Values are means + standard deviation.* indicates significantly 
different than SFA2, SFA5, PA2 and PA5. Abbreviations: SFA5: superficial femoral artery five-minute 
occlusion, SFA2: superficial femoral artery two-minute occlusion, PA5: popliteal artery five-minute occlusion, PA2: 




5.4: Two-and Five-Minute Occlusion of SFA and PA 
As mentioned above there were no significant differences in baseline diameter, vascular 
resistance, vascular conductance or shear stress between the two leg conduit arteries examined, 
PA and SFA. Differences lay in the reactive hyperemia and FMD responses (Figure 13-16). As 
explained in chapter 3.6 a significance level of p<0.0125 was used as the criterion for statistical 
significance.  Any negative FMD value was considered as though no FMD i.e. FMD equal to 
zero; all positive percent FMD value were reported as is.  
5.4.1Reactive Hyperemia and FMD Responses 
 
5.4.1.1: SFA5 & PA5 
Of the 10 men studied only two had a significant SFA FMD response (FMD>4%) following 
five-minutes of calf occlusion. Conversely, when examining the PA response to five-minutes of 
occlusion, only one participant did not have a FMD response of greater than 4% (Appendix 
3:Table 3). There were statistically significant differences in peak shear, SSAUC and FMD 
between the SFA5 and PA5 conditions (p=0.0037, 0.0108 and 0.0120 respectively, Figures 13-
15). A borderline significant difference between SFA5 and PA5 FMD/SSAUC was seen (p= 
0.0349, Figure 16). No other significant differences were noticed when FMD was normalized, 




5.4.1.2: SFA5 and SFA2 
Of the 10 participants examined in the current study, only nine sets of SFA2 - data could be 
analyzed. No participant demonstrated a SFA FMD response to two-minutes of calf occlusion 
(Appendix 3: Table 3). Furthermore, no significant differences in peak shear, SSAUC, FMD, or 
FMD/SSAUC were found between the SFA5 and SFA2 conditions (Figure 13-16). Therefore, 
neither SFA protocol was able to elicit a significant increase in shear stress or percent FMD.  
5.4.1.3: PA5 and PA2 
 
When two- minutes of calf occlusion with one-minute of exercise was performed on the PA 
only 8 participants’ data could be analyzed. Of those, no significant increase in diameter was 
seen for three participants while the other five had an FMD response of greater than 4% 
(Appendix 3: Table 3). As mentioned above, 9 out of 10 participants had a significant FMD 
response to the PA5 protocol. With regards to peak shear, a borderline non-significant 
(p=0.0147) difference in peak shear was noticed. Based on the peak shear stress and SSAUC 
values recorded (Appendix 3: Table 4), it is likely that there is a significant difference in peak 
shear between the five and two minute occlusion protocols on the PA (Figure 13). There was a 
significant difference (p=0.0079) in the post occlusion shear response, SSAUC; however, there 
was no significant difference (p=0.396) in the percent PA FMD following either the five or two-




5.4.1.4: PA2 and SFA2 
 Comparing the two two-minute occlusion protocols revealed a few interesting findings. 
No participants had an FMD response in SFA2 protocol. Conversely, in the PA2 condition, 5 out 
of eight men had a significant FMD response. The baseline diameters between these two arteries 
were not significantly different (Figure 12, p= 0.3086). Furthermore, no significant differences in 
baseline vascular resistance, conductance or shear were observed (Figures 9-11). There was no 
significant difference in peak shear (Figure 13, p=0.0489), while there was a borderline 
significant difference in SSAUC (Figure 15, p=0.0173).  Therefore, when exposed to two-min of 
calf occlusion with one minute of exercise, the PA is more sensitive to the elicited shear stimulus 
and can produce a FMD response while the SFA cannot.  
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Figure 13: Peak shear stress in the superficial femoral and popliteal arteries after either two-or 
five minutes of occlusion. Values are means + standard deviation. * indicates significant 
difference compared with SFA5. ** indicates significant differences compared with PA2. 
Abbreviations: SFA5: superficial femoral artery five-minute occlusion, SFA2: superficial femoral artery two-minute 
























Figure 14: Percent flow mediated dilation in the brachial, superficial femoral and popliteal 
arteries after either two-or five-minutes of occlusion. Values are means + standard deviation.* 
indicates significant difference compared to SFA5 ** indicates significant difference compared 
with SFA2. Abbreviations: SFA5: superficial femoral artery five-minute occlusion, SFA2: superficial femoral 
artery two-minute occlusion, PA5: popliteal artery five-minute occlusion, PA2: popliteal artery two-minute 
occlusion 
Artery



































Figure 15: Shear stress area under the curve in the superficial femoral and popliteal arteries 
after either five-or-two-minute of occlusion. Values are means + standard deviation  * indicates a 
significant difference compared to SFA2. ** indicates a significant difference compared with 
SFA5. *** indicates a significant difference compared with PA2. Abbreviations: SFA5: superficial 
femoral artery five-minute occlusion, SFA2: superficial femoral artery two-minute occlusion, PA5: popliteal artery 





















Figure 16: Ratio of percent flow-mediated dilation to shear stress area under the curve. Values 
are means + standard deviation. Abbreviations: SFA5: superficial femoral artery five-minute occlusion, SFA2: 
superficial femoral artery two-minute occlusion, PA5: popliteal artery five-minute occlusion, PA2: popliteal artery 
two-minute occlusion 
 
5.5: Five-Minute Occlusion of BA, SFA, PA 
 
To examine the effect of artery location, i.e. upper and lower extremity, on the FMD response a 
five-minute occlusion was performed on the BA, SFA and PA. Baseline BA diameter was 
significantly smaller than that of the SFA5 and PA5; however, no difference between SFA5 and 
PA5 baseline diameter were found (Figure 12). Baseline shear stress and vascular conductance 
were significantly elevated in the BA compared with the SFA5 and PA5 (Figures 9 & 10), while 
there were no significant differences between the SFA5 and PA5. No significant differences in 
baseline vascular resistance were noted between the three arteries examined (Figure 11).  
 Using a one-way ANOVA, with significance determined for values of p<0.05, revealed 
significant differences between the FMD responses (F=7.51, p=0.0043), and SSAUC (F=46.95, 
p<0.001) of the BA, SFA and PA. A post-hoc analysis, Tukey test, with a significance level of 
0.05, revealed that that the FMD response of the BA and PA were not statistically different. 
However, the FMD responses of the BA and PA were significantly different than that of the SFA 
(Figure 17). Furthermore, all three arteries had statistically different SSAUC (Figure 18). When 
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the FMD response was normalized to the elicited shear stimulus, FMD/SSAUC, no significant 
differences were seen. There was a trend towards a lower FMD:SSAUC in the SFA5 compared 

















Figure 17: Percent flow-mediated dilation of the brachial, superficial femoral and popliteal 
arteries after five-minutes of distal occlusion. Values are means + standard deviation.* indicates 
significant difference as compared to the SFA. Abbreviations: BA5: brachial artery five-minute occlusion, 









































Figure 18: Shear stress area under the curve of the brachial, superficial femoral and popliteal 
arteries after five-minutes of distal occlusion. Values are means + standard deviation. * indicates 
significant difference as compared with the BA. ** indicates significant difference as compared 
with the SFA. Abbreviations: BA5: brachial artery five-minute occlusion, SFA5: superficial femoral five-minute 






















Figure 19: Ratio of percent flow-mediated dilation to shear stress area under the curve of the 
brachial, superficial femoral and popliteal artery after five-minutes of distal. Values are means + 
standard deviation. Abbreviations: BA5: brachial artery five-minute occlusion, SFA5: superficial femoral five-
minute occlusion, PA5: popliteal artery five-minute occlusion. 
Within–artery comparisons were performed on the SFA, PA and BA. When examining the 
differences between arm and leg conduit arteries the PA was compared to the BA. SFA data 
were not compared to those of the BA, because the current protocol using five-minutes of calf 
occlusion was unable to elicit a FMD response larger than 4%. 
When SSAUC was plotted against diameter, a strong negative correlation was seen for both the 
BA and PA (BA r=-0.6321, PA r=-0.7782, p<0.05). These data suggest that the larger the arterial 
diameter the smaller the SSAUC response (Figure 20). When percent FMD and FMD:SSAUC are 


























Figure 20: Shear stress area under the curve plotted against baseline diameter for the brachial 
and popliteal arteries. Data points represent individual subject values. 
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Figure 21: Percent flow-mediated dilation plotted against baseline diameter for the brachial and 





























Figure 22: Flow-mediated dilation normalized to shear stress area under the curve plotted 
against baseline diameter of the brachial and popliteal arteries. Data points represent individual 
subject values. 
 Comparison of the two leg conduit artery responses to five-minutes of distal calf 
occlusion was examined via correlation plots. Correlation graphs of percent FMD, SSAUC and 
FMD:SSAUC as a function of baseline diameter for the PA and SFA post five-minutes of calf 
occlusion  are seen below (Figures 23-25). When SSAUC was plotted against baseline diameter a 
strong negative correlation (r= -0.7782) was seen in the PA, while a weak negative correlation 
(r=-0.1768) was seen in the SFA.  When percent FMD was plotted as a function of baseline 
diameter a weak negative correlation was seen for both the SFA and PA (PA r= -0.1296, SFA 
r=0.0250). Similarly, the plot of FMD:SSAUC as a function of baseline diameter  revealed weak 
correlation for the PA (r=0.284) and no noticeable trend for the SFA (r= -0.0596).  
61 
 
Baseline D iameter (cm)

















Figure 23: Shear stress area under the curve plotted against baseline diameter for the popliteal 
and superficial femoral arteries.  Data points represent individual subject values. 
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Figure 24: Percent flow-mediated dilation plotted against baseline diameter for the popliteal and 
superficial femoral arteries. Data points represent individual subject values 
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Figure 25: Flow-mediated dilation normalized to shear stress area under the curve plotted 
against baseline diameter for the popliteal and superficial femoral arteries. Data points represent 
individual subject values 
 
5.6: Edge and Center Method of Determining Artery Diameter 
In the current study seven participants BA were analyzed using both the traditional edge-
detection method and the center-based method. The usefulness of the new method was compared 
using a paired T-test; a significance level of p<0.05 was used. Using the center-based method did 
not produce a significant difference in percent FMD as compared with the edge-detection 
method (F=0.05, p=0.8259, Figure 26). Furthermore, the time to FMD was not significantly 
different between the two methods (F=2.08, p=0.2996, Figure 27). An example of one subject’s 
FMD profile can be seen in Figure 28. Although the center-based method did not result in a 
significantly different FMD response, using the center-based method resulted in a larger measure 
of diameter at all time points; the direction of this trend does not hold true for all subjects (See 
Appendix 4: Table 4).  
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Artery D iameter Determin ing M ethod













Figure 26: Percent flow-mediated dilation determined using the traditional edge detection 
method (M1) and the new center-based method (M2). No significant differences were seen. 
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Figure 27: Time to flow-mediated dilation determined using the traditional edge-detection 
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Figure 28: A single participant’s diameters measured from baseline (time 0) through till 
2:30min post deflation. The open circles represent diameters determined with the traditional edge 
detection method, while the closed circles represent diameters determined via the center-based 
method. 
A Bland-Altman plot was used to compare the percent FMD results obtained using the center-
based and edge-detection method (Figure 29); a full table associated with this plot can be seen in 
Appendix 4, Table 5. The Bland-Altman plot demonstrates that the majority of the data, except 
one data point, falls within the associated 95% confidence interval or two standard deviations of 
mean difference between the two methods. This plot further strengthens the usefulness of the 
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Figure 29: Bland Altman plot of the difference in percent FMD between the center-based and 

















Chapter 6: Discussion 
Before the current study was undertaken a reproducibility study was performed which 
determined that the FMD results observed are reproducible. This was accomplished by testing 
the hypothesis that there would be no significant differences in baseline diameter, peak diameter, 
percent FMD, peak shear stress, SSAUC, and time to FMD. Once the reproducibility study was 
completed the main study set out to examine the following hypotheses: First, the shear stress and 
FMD responses of the SFA and PA will not be significantly different due to a five-minute 
occlusion protocol, thereby permitting leg conduit artery FMD tests to be performed on the more 
accessible SFA. Secondly, no significant difference in FMD and shear stress responses between 
the five and two-minute occlusion protocols will be seen for either the SFA or the PA, allowing a 
shorter duration occlusion protocol to be used. Thirdly, no significant difference in the FMD and 
shear stress responses will be seen between the two-minute occlusion protocol performed on the 
SFA and PA.  Fourthly, significant difference between BA, SFA and PA percent FMD and shear 
stress responses to five-minutes of occlusion will be used to examine the effects that baseline 
diameter and extremity have on endothelial function. Finally, the use of the center-based method 
of measuring artery diameter will be validated; no significant differences were expected in 





6.1: Main Findings 
The current project set out to answer the above-mentioned five hypotheses; the results of the 
current study support all of the hypotheses. The main findings of the current experiment are 1) 
Results of the reproducibility demonstrated that baseline and peak diameter measurements are 
reproducible (see Chapter 4);  2)The baseline characteristics (shear stress, diameter, vascular 
resistance and vascular conductance) of the BA are significantly different than those of the SFA 
and PA; however, there are no significant differences between SFA and PA baseline 
characteristics; 3) The reactive hyperemia shear stress and FMD responses of BA due to five-
minutes of distal occlusion are significantly different than those of the PA and SFA; 4) Five-
minutes of lower limb occlusion results in significantly different peak shear stress, SSAUC and 
FMD responses between the SFA and PA; 5) When testing the PA, a two-minute occlusion 
containing one minute of exercise can be used instead of a five-minute occlusion; however, the 
same does not hold true for the SFA; 6) Preliminary testing demonstrated the usefulness of using 




6.2: Baseline Characteristics 
The BA, SFA and PA baseline diameter values reported in the current study are in line with 
previous research; BA baseline diameter was 0.42 cm, SFA was 0.67 cm and the PA was 0.69 
cm. Previous research has reported PA baseline diameter ranges between of 0.60 and 0.7cm (48; 
50; 69). With regards to the SFA a wider range of baseline diameters have been reported; 
Thijssen et al. reported SFA baseline diameter to be 0.77cm (69), while Walther et al. reported a 
SFA baseline diameter of 0.63 cm in young healthy normotensive males. BA baseline diameter 
has been reported to range from 0.40 cm to 0.47 cm (36; 69; 73).   
In the current study no significant differences were seen between baseline diameters of the SFA 
and PA. Furthermore, a wide range of baseline SFA diameters have been reported in the 
literature.  These findings can, at least partially, be explained by the location of diameter 
measurements. Previous SFA FMD protocols have used distal thigh occlusions, and therefore 
arterial diameter must have been measured farther up on a participant’s thigh, closer to the hip. 
Conversely, in the current study a distal calf occlusion was used which allowed SFA diameter 
measurements to be taken lower on a participant’s thigh, closer to the knee. The location of 
diameter measurement can have a significant impact on baseline and peak diameter. A MRI 
study performed by Wood et al. suggested that as the SFA descends the thigh diameter decreases 
by approximately 5% (79). In the current study, SFA diameter was measured approximately 11 
cm or four inches from the medial epdicondyl. Thus, the lower SFA diameter reported in the 
current study compared to the work of Thijssen et al.(69) and Kooijman et al. (36) can largely be 




Based on available literature, baseline characteristics of the BA were expected, and in fact 
were, significantly different than the PA and SFA (Figure 9-12). Differences in baseline diameter 
between the upper and lower extremity has been attributed to adaptations to the force of gravity 
(72) and due to differences in the volume of tissue perfused by the arteries (48). The greater 
muscle mass perfused by the SFA and PA results in a higher absolute blood flow and percent Q 
in the legs compared to the arms. Exposure to a greater volume of blood and thus shear stress 
may also lead to vascular smooth muscle cell and EC adaptations.   
An important factor regulating the differences in limb conduit artery baseline tone is vascular 
adaptations due to the effects of gravity(16).  On average, North Americans spend greater than 
two-thirds of their day in an upright posture; which exposes the leg to 65 mmHg greater pressure 
than the arms (39). Eiken & Kolegard speculated that the lower limb has adapted to this 
increased gravitational pressure via “vascular stiffening” (20).  This is reflected in the different 
factors mediating baseline vascular tone in the arms compared to the legs; leg conduit arteries 
experience greater SNS vasoconstrictor mediation (52), whereas the BA is more sensitive to 
circulating vasodilators (45). Leg “vascular stiffening” has been suggested to affect the 
decreased responsiveness due to increased shear stress (48) and the reason behind the increased 
susceptibility of the SFA to atherosclerotic lesion formation (51).  More work is still needed to 
understand the importance of these differences and how they can affect FMD.    
In the current study, baseline BA shear stress was approximately 75% larger than that of the PA 
or SFA. This is supported by baseline wall shear rate data from Wu et al., who reported that BA 
mean wall shear rate is approximately 50% larger than that of the SFA (80). Variation in the 
magnitude of the limb differences in baseline shear stress between current study and the data 
presented by Wu et al. are likely due to methodological differences; Wu et al. used MRI images 
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where as in the current study Doppler Ultrasound was used(80). Newcomer et al. confirmed the 
finding of Wu et al. using Doppler ultrasound. Newcomer and colleagues reported that when a 
subject is resting in the supine position, BA shear stress is significantly larger, 40%, than that of 
the SFA (46); furthermore, Nishiyama et al. reported that BA shear stress is 37.5% larger that of 
the PA (48). Animal research has suggested that lower shear stress may result in down-regulation 
of eNOS resulting in a decrease in NO available to stimulate underlying vascular smooth muscle 
cells. If this holds true for humans, then the lower resting shear stress of the PA and SFA would 
result in less NO being available to respond to the RH stimuli post limb occlusion and thus a 
smaller FMD response (25). It is apparent that differences in BA, SFA and PA baseline shear 
stress contribute to limb differences in FMD. More work is still needed to understand the 
pathways affected by the lower shear stress experienced by leg conduit arteries and how these 
changes relate to lower limb FMD responses.  
6.3: Normalizing a Flow-Mediated Dilation Response 
In the current study FMD responses are reported as a percent increase of baseline diameter and 
normalized to SSAUC until 20 seconds post deflation. Pyke & Tschokovsky recommended that 
the change in diameter needs to be reported in reference to the magnitude of the shear stimulus, 
which is believed to be the primary mechanism guiding the increase in diameter (56). They 
recommended that the shear stimulus be recorded until the achievement of peak diameter. In the 
present study the ultrasound machine used was unable to capture simultaneous arterial diameter 
and velocity measurements. This technological limitation prohibited SSAUC from being measured 
until peak diameter was achieved; instead SSAUC was calculated until 20 seconds post deflation. 
This time point was chosen because it encompassed peak shear stress for all subjects. To 
elaborate, the post deflation increase in shear stimulus peaks and decays long before peak 
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diameter is achieved; however, shear stress does not return to baseline levels until a few minutes 
post deflation (56). Furthermore, research has demonstrated that both peak shear stress and the 
duration of the shear stimulus are determinants of peak FMD (31). Conversely, Dyson reported 
that peak shear is not an important determinant of a FMD response(19). As the importance of 
peak shear or total shear stress has yet to be uncovered, the current study calculated SSAUC until 
just after peak shear was accomplished. Throughout the discussion, FMD will be reported as 
both a percent and normalized to SSAUC.  
6.4: Differences in Popliteal and Superficial Femoral Artery FMD Responses 
6.4.1: PA & SFA FMD Responses to Five-Minutes of Occlusion 
The current study examined the shear stress and FMD responses of the SFA and PA to the same 
occlusion protocol; a five-minute distal calf occlusion at 220 mmHg. Of the 10 participants 
tested in the current study, only two had a SFA FMD response greater than 4%. These findings 
are not in agreement with previous investigations that have used thigh cuffs. Previous 
investigations (13; 64; 65; 70; 73; 73) have reported SFA FMD between 4% and 7.5%, while one 
study (73) reported SFA FMD to be 2%, which is more in line with value obtained in the current 
study (Appendix 5: Table 6) post five-minutes of distal thigh occlusion. Conversely, the current 
study reported that PA FMD was 6.5%, and nine out of ten participants had a “clinically” 
significant (>4%) FMD response.  The average PA FMD response found in the current study is 
in agreement with previous literature, that has reported PA FMD values of 6.1%(69), 4.5%(48) 
and 4% (51). In the current study, when FMD was normalized to SSAUC, no significant 
differences between PA5 and SFA5 were noted; however, there is a noticeably lower 
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FMD/SSAUC of the SFA5 compared to the PA5. The lack of significance is most likely due to the 
large standard deviation associated with these values.   
The inability of the distal calf occlusion protocol to elicit a SFA FMD greater than 4% may be 
due to differences in reactive hyperemia shear stress response produced post cuff release. Five-
minutes of SFA occlusion elicited an average peak shear of approximately 200 s
-1
, which is 
significantly lower than PA peak shear, approximately 400 s
-1
. When the SSAUC was calculated, 
until 20 seconds post deflation, average SFA SSAUC was 3740 and average PA SSAUC was 6085. 
These data demonstrate that calf occlusions can elicit a strong enough shear stimulus in the PA 
but not in the SFA. Previous research has shown that thigh cuffs are able to elicit a strong shear 
stress reaction in the SFA; Thijssen et al. (2008) reported that SFA SSAUC until peak diameter 
(172 seconds post deflation), was 14541 (69). The work of Thijssen et al. suggested that peak 
SFA diameter, post cuff release, occurred almost two and a half minutes post deflation. In the 
current study, SFA diameter was not measured past two and half minutes post deflation(69), 
which could mean that peak diameter and thus the true FMD response was not measured. 
However, caution must be taken when analyzing the results of Thjissen et al. as these researchers 
reported a longer time to peak diameter for all arteries examined as compared to previous 
researchers. Briefly, Thijssen et al. reported that peak BA was reached at 85 seconds post 
deflation (69) whereas Padilla et al. reported that peak diameter was reached around 60 seconds 
post deflation (51). Most studies report peak diameter to occur well under two and a half minutes 
post deflation; furthermore, in the current study after peak diameter was seen arterial diameter 
began to return to baseline values (Figure 28). Based on these findings, it is unlikely that peak 
diameter was missed and therefore the lack of a SFA FMD response in the majority of 
participants might be attributed to the small shear stress response. The weak shear stress and low 
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FMD response of the SFA to distal calf occlusions suggests that this occlusion protocol cannot 
be used to examine SFA endothelial health.  If SFA function is to be examined then previous 
literature suggests that a distal occlusion with the cuff wrapped around the participant’s thigh is 
the most appropriate protocol.  
Based on the similarity in magnitude of SFA and PA FMD values reported by other researchers 
(36; 48; 51; 65; 69) it is tempting to conclude that either the SFA or PA could be used to 
examine lower limb vascular health. However, results from Walther et al. and Silber et al. 
contradict this idea by reporting small SFA FMDs of 2% (73) and 3.5% (64; 73) respectively. 
These values are much lower than the above reported PA FMD values and call in to question the 
ability of the SFA to be examined in place of the PA. Furthermore, results from the current study 
support the notion that the SFA cannot be used in place of the PA to examine lower limb conduit 
artery function.  
The lack of a FMD response in the SFA when exposed to the same occlusion protocol as that 
used to examine PA FMD was an unexpected finding. Previous work examining SFA FMD 
placed the pneumatic cuff around the participant’s thigh, just above the knee. Conversely, when 
examining the PA, the cuff is placed around the participant’s calf, just below the knee joint 
(Appendix 5: Table 6).  The location of diameter and velocity measures could explain the wide 
range of baseline SFA diameters reported in the literature and can partially explain the lack of 
SFA FMD reported in the current study.  It is possible that there could be minor anatomical and 
physiological differences between the proximal and distal ends of the SFA that could alter the 
artery’s ability to respond to shear stress and produce a FMD response to the reactive hyperemia 
following temporary limb ischemia. More work is needed to investigate this issue and determine 
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the optimal measurement site and stimulus protocol for the SFA when performing a FMD 
protocol.  
As outlined in the BA FMD guidelines, inflating a pneumatic cuff to pressures at least 50 
mmHg above systolic blood pressure results in tissue ischemia distal to the occlusion site. This 
ischemia results in dilation of downstream resistance vessels which drives the high flow state 
post deflation necessary to increase blood supply to the dilated resistance vessels (14). Placing 
the pneumatic cuff around the participant’s thigh may result in a larger amount of tissue being 
ischemic compared to calf occlusions. The increased volume of occluded tissue may cause more 
metabolites to be produced and accumulate in downstream resistance vessels. The increased 
volume of occluded tissue could cause a greater reactive hyperemia and in turn larger shear 
stress stimulus upon cuff release. However, there is no branching in the SFA as it descends the 
thigh, suggesting that in the tissues supplied by the SFA there may not be an increase in ischemic 
tissue volume and a subsequently larger reactive hyperemia due to a thigh versus calf cuff 
placement. More work is needed to uncover if there are differences in distal micro-vessel 
resistance due to differences in cuff placements or whether there are differences in the properties 
of the SFA as it descends the leg and becomes the PA. It is possible that on top of a decrease in 
arterial diameter as the SFA descends the thigh (79) there could be differences in the receptor 
number and or function at different artery locations. It is important to study theses differences in 
order to uncover the possible contributor(s) to the lack of SFA FMD reported in the current study 
when a distal calf cuff was used. Therefore, it is possible that differences in cuff placement 
between the current study and other investigations (36; 65; 69), although all distal to the site of 
measurement, might explain why the SFA had a FMD response in previous studies but not in the 
current one.   
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In conclusion, the results of the current study demonstrate that temporary limb ischemia due to 
distal calf occlusion can elicit a PA FMD response but not a SFA FMD response. More work is 
needed to determine the optimal leg conduit artery FMD protocol so that researchers and 
clinicians can fully understand leg conduit FMD and its inferences for a participant’s overall 
vascular health.  
6.4.2: Comparison of PA FMD in Response to either a Five or Two-Minute Occlusion 
Previous experiments on BA FMD have manipulated occlusion duration to determine the 
shortest occlusion protocol that can be used to achieve a significant FMD response. Nishiyama et 
al. manipulated occlusion duration using distal cuff placement. With a five-minute occlusion, 
FMD was 6.5%, conversely with a three-minute occlusion FMD was dramatically reduced to 
0.7%; furthermore, this trend holds when FMD data were normalized the SSAUC (48). These data 
suggest that shorter duration distal occlusions, without the addition of exercise, are insufficient to 
increase shear stress and elicit a significant BA FMD response. The above findings are supported 
by a recent study by Padilla et al.; they reported that occlusion durations less than four-minutes 
are unable to elicit a large enough shear stress to produce a FMD response similar to that 
produced after five-minutes of occlusion (50). However, when the FMD response was 
normalized to the SSAUC, no differences due to occlusion duration were seen (50). Therefore, 
based on the findings of Padilla et al. (50) five-minutes of forearm occlusion is the shortest 
occlusion that can be used to assess endothelial function and NO bio-availability.  
The current study aimed to examine if a shorter duration occlusion protocol could achieve 
significant FMD response. In the lower limb, the traditional five-minute occlusion was compared 
to a two-minute occlusion containing one-minute of exercise. One minute of exercise was added 
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in order to help augment the shear stimulus; participants were asked to apply a pressure of 100 
mmHg to the footplate. As young healthy males were examined this amount of force was 
considered light exercise. PA FMD, both percent and normalized to SSAUC, was not significantly 
different when the shorter duration protocol was used. The shorter occlusion protocol elicited a 
significant FMD response in five of the eight participants. It would be useful to examine two-
minute occlusions containing a slightly harder exercise protocol in order to produce a slightly 
larger shear stress response and therefore  a significant FMD response (>4%) in all participants.  
Although peak shear stress and SSAUC were significantly different between the five and two-
minute protocols, the elicited stimulus in both cases was sufficient to cause a significant increase 
in diameter. When the ratio of FMD: SSAUC was examined, no significant differences between 
the two protocols were seen. It appears that two-minutes of occlusion with one-minute of 
exercise can be used to instead of the traditional five minute protocol to examine PA FMD. The 
current study appears to be the first to demonstrate the usefulness of shorter duration occlusions 




6.4.3: Comparison of SFA Responses to Five and Two-Minutes of Calf Occlusion 
This study determined that five-minutes of calf occlusion only elicited a significant SFA FMD 
(>4%) in 20% of the subjects. When the two-minute protocol was performed on the SFA, 
exercise was added to augment the shear stimulus; however, the occlusion duration, even with an 
exercise component, was insufficient to elicit a significant increase in percent FMD. No 
significant difference between SFA2 and SFA5 peak shear and SSAUC were noted; however, 
there was a trend for SFA2 to have a lower peak shear and SSAUC than the SFA5 condition. It 
appears that this decrease was sufficient to abolish an FMD response from being produced. 
When the FMD: SSAUC ratio was examined, no significant difference was seen; however, both 
data sets contained large standard deviations; therefore care must be taken when interpreting 
those data. Based on the above findings it can be concluded that both the two and five-minute 
calf occlusion protocols are unable to elicit a significant SFA FMD response.   
In summary, five-or two-minute calf occlusions can be performed on the PA to elicit a 
significant FMD response. However, when examining the SFA, short duration calf occlusions 
are unable to elicit a sufficient stimulus to cause an FMD response. Therefore, based on previous 




6.5: Limb differences in Shear Stress and FMD after Five-Minutes of Occlusion 
Previous research has validated the usefulness of studying BA FMD as the magnitude of the 
FMD response provides a good indicator of the participant’s endothelial health and NO bio-
availability. In patients with CVD, or its associated risk factors, BA FMD is found to be less than 
4% (13). However, it is important to examine lower limb FMD responses because recent studies 
have reported that the SFA demonstrates a higher propensity than the BA of developing 
atherosclerotic lesions (43). 
In the current experiment, the SFA, PA and BA were all subjected to five-minutes of distal 
occlusion at 220 mmHg. The BA (8.9%) and PA (6.5%) FMD values obtained in the current 
study are in line with those obtained by previous researchers (Appendix 5: Table 6). It is difficult 
to compare the SFA FMD results obtained in the current study to results from previous 
experiments because different cuff positions were used. In the present experiment SFA FMD 
was, 1.6% FMD which disagrees with previous literature reporting SFA FMD to range between 
4 and 7.5%. As highlighted above (Chapter 6.4), the resulting stimulus from a calf occlusion was 
insufficient to significantly alter SFA diameter; therefore, when comparing limb differences, 
only the BA and PA values will be examined.  
In the current study, although there was a trend for BA FMD (8.9%) to be higher than PA FMD 
(6.5%) this difference was not significant. Furthermore, when FMF:SSAUC data were compared 
between the BA and PA, no significant differences were reported. Previous investigations have 
confirmed the impact of baseline arterial diameter on the resulting percent FMD response (13; 
29; 36; 60; 71). As an example, Thijssen et al. examined the femoral artery, SFA, PA, BA and 
RA and demonstrated that smaller conduit arteries have larger percent FMD responses than 
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larger arteries. In order of size, femoral artery FMD was 3.9%, SFA FMD was 6.9%, PA FMD 
was 6.1%, BA FMD was 7.0, and RA FMD was 9.4% (69). However, when FMD was corrected 
for the elicited stimulus, no significant differences between SFA, PA, BA and RA responses 
were found. These data demonstrate the relationship between baseline diameter and FMD 
responses; smaller conduit vessels produce larger FMD as compared to larger conduit arteries in 
response to five-minutes of distal occlusion (69).  
Previous investigations have shown a correlation between baseline diameter and the magnitude 
of the increase in diameter. Pyke and Tschakovsky reported a correlation of r
2
= 0.64(57), 
Thijssen et al. r
2
= 0.33 (69) and Pyke et al. r
2
=0.14 (53). In the current experiment a correlation 
of r
2
=0.11 was found, which is similar to the findings reported by Pyke and colleagues(53). 
When percent FMD was plotted as a function of baseline diameter, Thijssen et al. reported an 
attenuation of the slope with increases in baseline diameter (69). They concluded that baseline 
diameter may not be an important contributor to the magnitude of an FMD response in large 
conduit such as the SFA or PA. This trend was also seen in the current experiment; correlation 
decreased to r
2
= 0.02 for the PA artery which had a significantly larger baseline diameter than 
the BA. There are many limitations to using correlation analysis and many assumptions need to 
be made such as the assumption of normality and linearity(75). Care must be taken when 
employing a correlation analysis, as this analysis method might minimize the relationship 
between baseline diameter and the magnitude of the FMD response that has previously been 
reported (69). More work is needed to understand the link between baseline and peak diameter 
and how this relationship affects a researcher’s interpretation of a FMD test.   
Differences in the percent FMD reported between the BA and PA must be discussed in 
conjunction with the differences in shear stress post five-minutes of occlusion. Five-minutes of 
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distal occlusion resulted in significantly greater BA SSAUC compared to the PA, which is 
supported by previous research. Nishiyama et al. reported a BA SSAUC of 25,419 and PA SSAUC 
of 8,089, therefore BA SSAUC is three times greater than that of the PA (48). Although SSAUC 
was calculated until a different time point in the current study, the trends still holds true; BA 
SSAUC was found to be two times greater than PA SSAUC. Research has suggested that the 
significantly larger shear stress and FMD responses of the BA, compared to the PA, are due to 
PA “vascular stiffening”(48). Eiken and Kolegard explained that leg conduit arteries have 
adapted to elevated levels of intramural pressure by increasing wall stiffness (20). Therefore, the 
structural differences in arm and leg vasculature are expected to result in different responses to 
five-minutes of distal occlusion.  
Correlation analysis has been performed to examine the relationship between arterial baseline 
diameter and the shear stress responses post occlusion. To reiterate,  shear stress is directly 
proportional to blood flow velocity and viscosity and inversely related to vessel diameter (15). 
The inverse relationship between diameter and shear stress was demonstrated in the current 
investigation, by a strong negative correlation between baseline diameter and SSAUC, BA r=-
0.6321, PA r=-0.7782, p<0.05 (Figure 20); Figure 20 demonstrates how shear stress post 
occlusion is strongly determined by baseline arterial diameter. The current experiment 
demonstrated a significantly lower PA SSAUC than BA SSAUC (Figure 18); this plot infers that 
larger conduit arteries exhibit lower post occlusion shear stress than smaller conduit arteries. 
Pyke and Tschakovsky also demonstrated this relationship by examining how blood flow 
velocity and shear stress are altered when flow is held constant between different size arteries. 
When flow is held constant, larger arteries will experience smaller blood flow velocities and 
shear rates compared to smaller conduit arteries. The increased shear stress exerted on the 
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smaller artery is an important factor mediating the larger FMD response produced to five-
minutes of occlusion (56). Based on the results from the current study and the work of Pyke and 
Tschakovsky (56) it is clear that there is a strong link between baseline diameter and shear stress. 
It is likely that these differences in post occlusion shear stress are an important component of the 
limb differences in FMD responses.  
The differences in shear stress and FMD responses between leg and arm conduit arteries can be 
attributed to a variety of factors. One likely culprit is the increase of 65 mmHg in pressure in the 
legs compared to the arms. The idea that gravity plays a role in the decreased lower limb 
vascular reactivity is supported by data collected from the Berlin bed rest study. In that project, 
16 men were subjected to 52 days of head down bed-rest, a common model for ground based 
examinations of the effects of microgravity exposure. Post bed rest SFA FMD was increased 
inferring an improvement in endothelial function with the removal of the increased pressure 
otherwise placed on the lower limbs (8). The impact of increased intravascular pressure on 
endothelial-dependent vasodilatation can also be examined using an in-vivo model of aortic 
coarctation (49).  Aortic coarctation is a condition in which the aorta narrows near the insertion 
of the ductus arteriosus. This model allows researchers to examine the effects that increased 
intravascular pressure have on proximal vascular beds. This increase in pressure has been 
reported to lead to endothelial and vascular smooth muscle remodeling; as well as functional 
changes to the endothelium and vascular smooth muscle cells (49). Padilla et al. examined the 
effects of increased pressure on vascular reactivity via arm hanging. This position leads to a 15 
mmHg increase in intravascular BA pressure (51). Although this pressure is significantly lower 
than that exhibited in the legs it does allow researchers to study the effects of added pressure on 
endothelial function. Padilla et al. reported that a 15 mmHg increase in BA intravascular pressure 
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resulted in a significant reduction in BA shear stress, percent FMD and FMD:SSAUC(51). The 
above-mentioned studies suggest that the 65 mmHg additional pressure exerted on leg conduit 
arteries results in endothelial and vascular smooth muscle cell remodeling and functional 
changes. These changes will alter how the leg conduit arteries respond to an increase in shear 
stress when compared with arm conduit arteries (45). Therefore, EC and vascular smooth muscle 
cell adaptations result in different shear stress and FMD responses in the BA and PA due to five-




6.6: Arterial Diameter 
In the current study arterial diameter was measured using cross-sectional M-mode sweeps of 
arm and leg conduit arteries. Diameter was determined using a computer-assisted script called 
“edge-detection”; this script was run through MATLAB (see chapter 3.5.2 for more 
information). The use of computer-assisted diameter analysis over manual assessment was 
examined by Woodman et al (78). These researchers used both a phantom artery and an actual 
brachial artery and determined that computer-assisted analysis improves a researcher’s ability to 
detect significant changes in arterial diameter by significantly reducing observer error (78). 
These findings support those found in the pilot data stage of the current study that noted 
significant limitations with an older tool for measuring arterial diameter that required manual 
corrections. Therefore, a computer-assisted program was used to measure arterial diameter which 
provides further confidence in the diameter measures obtained in the current study. 
 Previous research examining conduit artery FMD responses have chosen to use longitudinal 
images; however, Kao et al. demonstrated significant limitations with longitudinal images, which 
are not present when using cross-sectional images (33). The validity of capturing arterial 
diameter in the transverse plane was very recently validated by Stroz & Fenster(66).  They 
reported no significant difference between measurements made in the longitudinal or transverse 
plane (66). Furthermore, the choice of M-mode sweeps, over traditional B-mode images was 
validated by Kelly et al.; these researchers demonstrated a close agreement in diameter and FMD 
measures captured using M-mode sweeps in comparison to B-mode images(34). Therefore, the 
decision to use two-dimensional cross-sectional M-mode sweeps of conduit arteries as a method 
of measuring arterial diameter is supported by previous literature.  
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In the current study, baseline diameters for the BA, SFA, and PA were 0.41, 0.67 and 0.66 cm 
respectively; similar values have also been reported by other investigators (6; 7; 51; 69; 71; 73). 
Previous literature has reported that baseline BA diameter ranging from 0.35 to 0.47 cm, SFA 
diameters between 0.63 to 0.78 cm and finally PA diameters between 0.60 and 0.70 cm 
(Appendix 5: Table 6). The baseline arterial diameter values measured in the current study are in 
agreement with previous studies which further increases confidence in the validity of cross-
sectional measurements of arterial diameter.  
Arterial diameter is measured between the media-lumen echo of the near wall to the intima-
lumen echo of the far wall (13; 14; 77). Due to limitations in ultrasound image resolution, artery 
diameter is measured between different structures on the near and far wall of the artery. An 
alternate method of measuring diameter was devised that would measure the distance between 
the same point on the near and far arterial walls. This method is called the center-based method; 
it determines arterial diameter based on the distance between the center of the media layer on the 
near wall to the center of the media layer on the far wall. Analysis using this method was tested 
using BA baseline and post deflation images from seven subjects. Although this is a small 
sample it provides insight into the usefulness and limitations of this method. Images from the BA 
were chosen, over those of the SFA and PA, because there is more data available regarding the 
ranges of BA FMD in young healthy adults. A one-way ANOVA revealed no significant 
differences in percent FMD and time to FMD using the center-based method as compared to the 
traditional edge-detection method. No obvious trend regarding the magnitude and direction of 
the differences using the center based method were observed. These two methods were put 
through further analysis using a Bland-Altman plot of the percent FMD obtained using both 
methods. The plot reveals that arterial diameters obtained using the center-based method are in 
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agreement with those values obtained using the edge-detection method.  Based on the above-
described preliminary findings, further analysis of the usefulness of the center-based method is 
warranted.  
6.7: Conclusions 
The results of the current study have helped to further outline the possibilities and limitations 
that need to be considered when performing a FMD protocol. The current study demonstrated 
that five-or two-minutes of distal calf occlusion are unable to elicit a SFA FMD response; 
therefore when examining leg conduit artery health distal calf occlusions can only be used on the 
PA. With regards to the PA, the current study demonstrated that a two-minute distal occlusion 
containing one-minute of static calf exercise can be used instead of the five-minute occlusion. 
These results suggest that a shorter occlusion protocol can be used to examine leg conduit artery 
health with no loss of quality. The current study performed comparisons between arm and leg 
vasculature by comparing the shear stress and FMD responses of the BA and PA. These results 
highlight the differences in these arteries both at baseline and due to five-minutes of distal 
occlusions. Research has convincingly demonstrated that these differences are due to leg conduit 
arterial adaptations to the force of gravity. Lastly, preliminary findings from the current study 
suggest that the center-based method of measuring arterial diameter can be used in place of the 





There are a few limitations associated with the current experiment. The current experiment was 
only performed on men, no women were examined. Therefore, the results of the current 
experiment can not be extrapolated to include all young healthy adults. Therefore more testing is 
needed to examine the different protocols in young adult females and in older men and women. 
This would allow researchers to gain a more complete picture of the ideal FMD protocol for 
testing leg conduit artery function and what this value infers of a patient’s overall vascular 
health.  
 A second limitation of the current study is that the ultrasound machine used was unable to 
simultaneously measure arterial diameter and blood flow. As a consequence, SSAUC could not be 
calculated until peak diameter was achieved as recommended by Pyke and Tschakovsky (56). 
Therefore in the current study SSAUC was determined until 20 seconds post cuff deflation, this 
time point encompassed the participant’s peak shear in every test and provided adequate time for 
the probes to be switched and a diameter measure to be captured at 45 seconds post deflation.  
The current study required that all participants abstain from caffeine, alcohol and physical 
exercise for 12 hours prior to testing and to consume a light low fat meal. The only way that the 
experimenters could insure that these guidelines were followed was by verbal confirmation with 
the subject prior to testing. It is possible that they participants did not accurately report their diet 
and liquid consumption which therefore could have altered a participant’s FMD response.  
As noted in the reproducibility section (Chapter 4) baseline and peak diameter were 
reproducible between testing days, however FMD was not. FMD is a calculated variable, which 
when run through statistical analysis is drastically affected by the differences associated with 
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each of its measured parameters. As described in equation 1, FMD is derived from subtracting 
peak diameter post deflation from baseline diameter and dividing that value by baseline 
diameter. Therefore, when running a correlation analysis on FMD, the error associated with 
baseline and peak diameter get multiplied which negatively affected the FMD response and 
resulted in the finding that FMD was not reproducible between testing days.     
6.9: Future Directions 
The current experiment demonstrated the potential usefulness of the center-based method of 
determining arterial diameter. Future studies should expand upon this and analyze a greater 
number of FMD tests, not only those performed on the BA. By improving the analysis tools used 
to measure arterial diameter more accurately a study will be able to detect small yet significant 
changes in diameter and thus FMD. 
 In order for a FMD test to provide insight in a patient’s peripheral and in turn coronary artery 
health, more work is needed to refine the available protocols and create a set of guidelines. An 
important protocol limitation that needs to be addressed is the ideal cuff placement. In the current 
experiment, calf cuffs were used to measure PA and SFA FMD responses. The lack of a SFA 
FMD due to this cuff position might be due to the fact that this occlusion protocol was unable to 
produce a significant reduction in downstream vascular resistance; therefore there was a smaller 
increase in blood flow/ shear stress post cuff release. The data demonstrate that this shear 
stimulus was unable to elicit a “biologically” significant FMD response. More work is needed to 
determine what factors contributed to the smaller shear response in the SFA post distal calf 
occlusion. This question would best be answered by future studies examining the difference in 
FMD responses due to distal occlusions using calf and thigh cuffs.  
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In further attempting to refine the available leg conduit artery FMD protocol determining the 
ideal occlusion duration and the usefulness of exercise is needed. The current study appears to be 
the first to demonstrate that a short two-minute occlusion with light intensity exercise can be 
used in place of the traditional five-minute protocol to examine PA vascular health. However, 
only five of the eight participants tested had a significant FMD response. Future work should 
examine a two-minute occlusion with a slightly harder intensity calf exercise to determine if that 
intensity can elicit a significant (>4%) FMD response in all participants. The more questions we 
answer regarding the FMD protocol, the more refined the guidelines can become, which would 
increase the clinical use and relevance of this non-invasive method of examining central and 
peripheral arterial health. More work is needed because a FMD test is a safe, reliable and 







 1.  Agewall S, Doughty RN, Bagg W, Whalley GA, Braatvedt G and Sharpe N. Compariosn 
of ultrasound assessment of flow-mediated dilation in the radial and brachial artery 
with upper and forearm cuff positions. Clin Physiol 21: 9-14, 2001. 
 2.  Alam TA, Seifalian AM and Baker D. A review of methods currently used for 
assessment of In vivo endothelial function. Eur J Vasc Endovasc Surg 29: 269-276, 
2005. 
 3.  Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman 
EH, Ganz P, Creager MA, Yeung AC and Selwyn AP. Close relation of endothelial 
function in the human coronary artery and peripheral circulation. J Am Coll Cardiol 
26: 1235-1241, 1995. 
 4.  Behrendt D and Ganz P. Endothelial function: from vascular biology to clinical 
application. Am J Cardiol 90: 40L-48L, 2002. 
 5.  Berry KL, Skyrme-Jones RA and Meredith IT. Occlusion cuff position is an important 
determinant of the time course and magnitude of human brachial artery flow-
mediated dilation. Clin Sci (Lond) 99: 261-267, 2000. 
90 
 
 6.  Betik AC, Luckham VB and Hughson RL. Flow-mediated dilation in human brachial 
artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol 
286: H442-H448, 2004. 
 7.  Black MA, Cable T, Thijssen DHJ and Green D.J. Importance of measuring the time 
course of flow-mediated dilation in humans. Hypertension 51: 203-210, 2008. 
 8.  Bleeker MWP, de Groot PC, Rongen GA, Rittweger J, Felsenberg D, Smits P and 
Hopman MTE. Vascular adaptations to deconditioning and the effect of an exercise 
countermeasure: results of the Berlin bed rest study. J Applied Physiology 99: 1293-
1300, 2005. 
 9.  Buckey JC, Lane LD, Levine BD, Watenpaugh DE, Wright SJ, Moore WE and Gaffney 
AF. Orthostatic intolerance after spaceflight. J Applied Physiology 81(1): 7-18, 1996. 
 10.  Bushberg JT, Seibert JA, Leidholdt EMJr and Boone JM. Ultrasound. In: The essential 
physics of medical imagine,  Philadelphia, PA, USA: Lippincott Wlliams and Wilkins, 
2002, p. 470-553. 
 11.  Calbet JA, Jensen-Urstad M, van Hall G, Holmberg HC, Rosdahl H and Saltin B. 
Maximal muscular vascular conductances during whole body upright exercise in 
humans. J Physiol 558: 471-476, 2004. 
91 
 
 12.  Carlsson I and Wennmalm A. Effect of different prostaglandin synthesis inhibitors 
on post occlusive blood flow in human forearm. Prostaglandins 26: 241-252, 1983. 
 13.  Celermajer DS, Sorensenm K.E., Gooch VM, Spiengelhalter DJ, Miller OI, Sullivan ID, 
Lloyd JK and Deanfield JE. Non-invasive detection of endothelial dysfunction in 
children and adults at risk for atherosclerosis. Lancet 340: 1111-1115, 1992. 
 14.  Corretti MC, Anderson TJ, Benjamin EJ, Celermajer DS, Charbonneau F, Creafer MA, 
Deanfield JE, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J and 
Vogel R. Guidlines for the ultrasound assessment of endothelial-dependent flow-
mediated vasodilation of the brachial artery. J Am Coll Cardiol 39: 257-265, 2002. 
 15.  Davies PF and Tripathi SC. Mechanical stress mechanisms and the cell: An 
endothelial paradigm. Circ Res 72: 239-245, 1993. 
 16.  de Groot PC, Poelkens F, Kooijman M and Hopman MTE. Preserved flow-mediated 
dilation in the inactive legs of spinal-cord injured individuals. Am J Physiol Heart Circ 
Physiol 287: H374-H380, 2004. 
 17.  Denniss SG. Endothelial vasomotor function after meal-induced hyperlipidemia: effect 




 18.  Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ and Goodfellow J. Flow-
mediated dilation following wrist and upper arm occlusion in humans: the 
contribution of nitric oxide. Clin Sci (Lond) 101: 629-635, 2001. 
 19.  Dyson KS, Shoemaker JK and Hughson RL. Effect of acute sympathetic nervous 
system activation on flow-mediated dilation of brachial artery. Am J Physiol Heart 
Circ Physiol 290: H1446-H1453, 2006. 
 20.  Eiken O and Kolegard R. Comparison of vascular distensibility in the upper and 
lower extremity. Acta Physiol Scand 181: 281-287, 2004. 
 21.  Ferguson DW, Berg WJ and Sanders JS. Clinical and hemodynamic correlates of 
sympathetic nerve activity in normal humans and patients with heart failure: 
evidence from direct microneurographic recordings. J Am Coll Cardiol 16: 1125-
1134, 1990. 
 22.  Folkow B. Intravascular pressure as a factor regulating the tone of the small vessels. 
Acta Physiol Scand 17: 289-294, 1949. 
 23.  Furchgott RF and Zawadzki JV. The obligatory role of endothelial cell in the 
relaxation of arterial smooth muscle by acetylcholin. Nature 228: 373-376, 1980. 
93 
 
 24.  Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R and Patsch JR. Flow-
mediated vasodilation of the femoral and brachial artery induced by exercise in 
healthy nonsmoking and smoking men. J Am Coll Cardiol 38: 1313-1319, 2001. 
 25.  Gambillara V, Chambaz C, Montorzi G, Roy S, Stergiopulos N and Silacci P. Plaque-
prone hemodynaimcs impair endothelial function in pig carotid arteries. Am J 
Physiol Heart Circ Physiol 290: H2320-H2328, 2006. 
 26.  Giannotti G and Landmesser U. Endothelial Dysfunction as an early sign of 
atherosclerosis. Herz 32: 572, 2007. 
 27.  Gokce N, Keaney JF, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO and Vita 
JA. Predicitve value of noninvasively determined enothelial dysfunction for long-
term cardiovascular event in patients with peripheral vascular disease. J Am Coll 
Cardiol 41: 1769-1775, 2003. 
 28.  Govers R and Rabelink TJ. Cellular regulation of endothelial nitrix oxide synthase. 
Am J Physio Renal Physiol 280: F193-F206, 2001. 
 29.  Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, Burke GL, McBurnie 
MA, Morgan TM and Espeland ME. Brachial flow-mediated vasodilator responses in 
population-based research: methods, reproducibility and effects of age, gender and 
baseline diameter. J Cardiovasc Risk 8: 319-328, 2001. 
94 
 
 30.  Hill CE, Phillips JK and Sandow SL. Heterogeneous control of blood flow amongst 
different vascular beds. Med Res Rev 21: 1-60, 2001. 
 31.  Joannides R, Bakkali EH, Richard V, Benoist A, Moore N and Thuillez C. Evaluation of 
the determinants of flow-mediated radial artery vasodilation in humans. Clin Exp 
Hypertens 19: 813-826, 1997. 
 32.  Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C and Luscher TF. 
Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit 
arteries in vivo. Circulation 91: 1314-1319, 1995. 
 33.  Kao YH, Mohler ER, Arger PH and Sehgal C.M. Brachial artery: measurement of flow-
mediated dilation with cross-sectional US-technical validation. Radiology 228: 895-
900, 2003. 
 34.  Kelly AS, Kaiser DR, Dengel DR and Bank AJ. Comparison of B-mode and echo-
traching methods of assessing flow-mediated dilation. Ultrasound in Med & Biol 30: 
1447-1449, 2004. 
 35.  Kingwell BA. Nitric Oxide-mediated metabolic regulation during exercise: effects of 
training in health and cardiovascular disease. J FASEB 14: 1685-1696, 2000. 
95 
 
 36.  Kooijman M, Thijssen DHJ, de Groot PC, Bleeker MW, van Kuppevelt DH, Green DJ, 
Rongen GA, Smits P and Hopman MTE. Flow-mediated dilation in the superficial 
femoral artery is nitric oxide mediated in humans. J Physiol 586: 1137-1145, 2008. 
 37.  Korkmaz H and Onalan O. Evaluation of endothelial dysfunction: flow-mediated 
dilation. Endothelium 15: 157-163, 2008. 
 38.  Laufs U, La Fata.V., Plutzky J and Liao JK. Upregulation of endothelial nitric oxide 
synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998. 
 39.  Levine JA, Lanningham-Foster LM, McCrady SK, Krizan AC, Olson LR, Kane PH, 
Jensen MD and Clark MM. Interindividual variation in posture allocation: possible 
role in human obeisity. science 307: 584-586, 2005. 
 40.  Mass M. A close look at the endothelium: its role in the regulation of vasomotor tone. 
European Urology Supplements 8: 48-57, 2009. 
 41.  McQuillan LP, Leung GK, Marsden PA, Kostyk SK and Kourembanas S. Hypoxia 
inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. 
Am J Physiol Heart Circ Physiol 267: H1921-H1927, 1994. 
 42.  Mombouli J-V and Vanhoutte PM. Endothelial dysfunction: from physiology to 
therapy. J Mol Cell Cardiol 31: 61-74, 1999. 
96 
 
 43.  Moore WS. Vascular Surgery: a comprehensive review. Philadelphia: W.B.Saunders 
Company, 2002. 
 44.  Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE and 
MacAllister RJ. Heterogenous Nature of flow-mediated dilation in human conduit 
arteries in vivo 
relevance to endothelial dysfunction in hypercholeterolemia. Circ Res 88: 151, 2001. 
 45.  Newcomer SC, Leuenberger UA, Hogeman CS, Handly BD and Proctor DN. Different 
vasodilator responses of human arms and legs. J Physiol 556: 1001-1011, 2004. 
 46.  Newcomer SC, Sauder CL, Kuipers NT, Laughlin MH and Ray CA. Effects of posture 
on shear rates in human brachial and superficial femoral arteries. Am J Physiol Heart 
Circ Physiol 294: H1833-H1839, 2008. 
 47.  Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, 
Alexander RW and Murphey TJ. Molecular cloning and characterization of the 
constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90: 
2092-2096, 1992. 
 48.  Nishiyama SK, Wray WD, Berkstresser K, Ramaswamy M and Richardson RS. Limb 
specific differences in flow-mediated dilation: the rold of shear rate. J Applied 
Physiology 103: 843-851, 2007. 
97 
 
 49.  Owens GK and Reidy MA. Hyperplastic growth response of vascualr smooth muscle 
cells following induction of acute hypertention in rats by aortic coarctation. Circ Res 
57: 695-705, 1985. 
 50.  Padilla J, Johnson BD, Newcomer SC, Wilhite DP, Mickleborough TD, Fly AD, Mather 
KJ and Wallace JP. Normalization of flow-mediated dilation to shear stress area 
under the curve eliminates the impact of variable hyperemic stimulus. Cardiovasc 
Ultrasound 6: 44-54, 2008. 
 51.  Padilla J, Sheldon RD, Sitar DM and Newcomer SC. Impact of acute exposure to 
increase hydrostatic pressure and reduces shear rate on conduit artery endothelial 
function: a limb specific response. Am J Physiol Heart Circ Physiol 297: H103-H108, 
2009. 
 52.  Pawelczyk JA and Levine BD. Heterogeneous responses of human limbs to infused 
adrenergic agonists: a gravitational effect. J Appl Physiol 92: 2105-2113, 2002. 
 53.  Pyke KE, Dwyer EM and Tschakovsky ME. Impact of controlling shear rate on flow-
mediated dilation responses in the brachial. J Appl Physiol 97: 499-508, 2004. 
 54.  Pyke KE, Hartnett JA and Tschakovsky ME. Are the dynamic responses 
characteristics of brachial artery flow-mediated dilation sensitive to the magnitude 
of the increase in shear stimulus? J Appl Physiol 105: 282-292, 2008. 
98 
 
 55.  Pyke KE, Poitras V and Tschakovsky ME. Brachial artery flow-mediated dilation 
during handgrip exercise: evidence for endothelial transduction of the mean shear 
stimulus. Am J Physiol Heart Circ Physiol 294: H2669-H2679, 2008. 
 56.  Pyke KE and Tschakovsky ME. The relationship between shear stress and flow 
mediated dilation: implications for the assessment of endothelial function. J Physiol 
568: 357-369, 2005. 
 57.  Pyke KE and Tschakovsky ME. Peak vs. total reactive hyperemia: which determines 
the magnitude of flow-mediated dilation. J Clin Invest 102: 1587-1595, 2007. 
 58.  Rakobowchuk M, McGowan CL, de Groot PC, Hartman JW, Philips SM and MacDonald 
MJ. Endothelial function of young healthy males following whole body resistance 
training. J Appl Physiol 98: 2185-2190, 2005. 
 59.  Rowell LB. Human cardiovascular control. New York: Oxford University Press, 1993. 
 60.  Schroeder S, Enderle MD, Baumbach A, Ossen R, Herdeg C, Kuettner A and Karsch 
KR. Influence of vessel size, age and body mass index on the flow-mediated dilation 
(FMD%) of the brachial artery. Int J Cardiol 76: 219-225, 2000. 
 61.  Seals DR and Dinenno FA. Collateral damage: cardiovascular consequences of 
chronic sympathetic nerve activity at rest in healthy humans. Am J Physiol Heart Circ 
Physiol 287: H1895-H1905, 2004. 
99 
 
 62.  Segal SS and Durling BR. Conduction og vasomotor responses in arterioles: a role for 
cell-to-cell coupling. Am J Physiol 256: H838-H845, 1989. 
 63.  Shoemaker, J. K. University of Western Ontarion Kinesiology 432 Course notes.  
2008.  
Ref Type: Unpublished Work 
 64.  Silber HA, Ouyang P, Bluemke DA, Gupta SN, Foo TK and Lima JAC. Why is flow-
mediated dilation dependent on arterial size? assessment of the shear stimulus 
using phase-contrast magnetic resonance imaging. Am J Physiol Heart Circ Physiol 
288: H822-H828, 2005. 
 65.  Sorensenm K.E., Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ and 
Deanfield JE. Impairment of endothelium-dependent dilation is an early event in 
children with familial hypercholesterolemia and is related to the lipoprotein (a) 
level. J Clin Invest 93: 50-55, 1994. 
 66.  Stroz MJ and Fenster A. Measuring flow-mediated dilation through transverse and 
logitudinal imaging: comparison and validation of methods. Phys Med Biol 55: 6501-
6514, 2010. 
 67.  Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Obsuzu F 
and Kurita A. Endothelium-dependent flow mediated vasodilation in coronary and 
100 
 
brachial arteries in suspected coronary artery disease. Am J Cardiol 82: 1535-1539, 
1998. 
 68.  Tarbell JM and Ebong EE. The endothelial glycocalyx: a mechano-sensor and -
transducer. Sci Signal 1: pt8, 2008. 
 69.  Thijssen DHJ, Dawson EA, Black MA, Hopman MTE, Cable T and Green D.J. 
Heterogeneity in conduit artery function in humans: impact of arterial size. Am J 
Physiol Heart Circ Physiol 295: H1927-H1934, 2008. 
 70.  Thijssen DHJ, Kooijman M, de Groot PC, Bleeker MWP, Smits P, Green D.J. and 
Hopman MTE. endothelium-dependent and -independent vasodilation of the 
superficial femoral artery in spinal cord-injured subjects. J Applied Physiology 104: 
1387-1393, 2008. 
 71.  Thijssen DHJ, van Bemmei MM, Bullens LM, Dawson EA, Hopkins ND, Tinken TM, 
Black MA, Hopman MTE, Cable T and Green D.J. The impact of baseline diameter on 
flow-mediated dilation differs in young and older humans. Am J Physiol Heart Circ 
Physiol 295: H594-H598, 2008. 
 72.  Ueno H, Kanellakis P, Agrotis A and Bobik A. Blood flow regulates the developement 
of vascualr hypertrophy, smooth muscle proliferation and endothelial cell nitric 
oxide synthase in hypertension. Hypertension 36: 89-96, 2000. 
101 
 
 73.  Walther G, Nottin S, Karpoff L, Perez-Martin A, Dauzat M and Obert P. Flow-
mediated dilation and exercise-induced hyperaemia in highly trained athletes: 
comparison of the upper and lower limb vasculature. Acta Physiol 193: 150, 2008. 
 74.  Wang XQ and Vaziri ND. Erythropoietin depresses nitric oxide synthase expression 
by human endothelial cells. Hypertension 33: 894-899, 1999. 
 75.  Weiss NA. Descriptive methods in regression and correlation. In: Elementary 
Statistics,  Prescott, Arizona: GregTobin, 2005, p. 150-198. 
 76.  Wesseling KH. Finometer (TM) user's guide. 2003. 
 77.  Wikstrand J. Methodolical considerations of ultrasound assessment of carotid 
intima-media thickness and luman diameter. Clin Physiol Funct Imaging 27: 341-
345, 2007. 
 78.  Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, Ruddy IB, 
Beilin LJ, Burke V, Mori TA and Green D. Improved analysis of brachial artery 
ultrasound using a novel edge-detection software system. J Applied Physiology 91: 
929-937, 2001. 
 79.  Woods NB, Zhao SZ, Jackson M, Gedroyc M, Thom SA, Hughes AD and Xu XY. 
Curvature and tortuosity of the superficial femoral artery: a potential risk factor in 
cardiovascular disease. J Appl Physiol 101: 1412-1418, 2006. 
102 
 
 80.  Wu SP, Ringgaard S, Oyre S, Hansen MS, Rasmus S and Pedersen ME. Wall shear 
rates differ between the normal carotid, femoral and brachial arteries: an in vivo 




 Appendix 1 

























AR 172 73 31 116 67 63 1030 2402.5 
DZ 179 75 22 119 67 53 950 1410 
CV 178 82 28 112 50 39 1000 1530 
CS 189 87 23 122 63 71 1010 3305 
AM 187 81 25 117 64 58 1090 1610 
RV 182 80 35 124 77 58 870 1775 
RS 183 72 26 120 70 63 1106 2670 
JW 179 97 28 121 72 80 950 2945 
BP 196 111 25 131 67 54 1090 3520 
DG2 176 75 26 120 72 66 905 2622.5 
Avg  182 83 27 120 68 61 1000 2379 
SD 7 12 4 5.06 5.38 11 81 763 
Min 




Value 196 111 35 131 77 
80 
1106 3520 











Table 2a: Average baseline, occlusion and deflation blood pressure and heart rate during 
the brachial artery five-minute occlusion protocol (n=10) 
Subject   MAP DBP SBP Q 
Heart 
rate 
1 rest 96 77 126 5.17 54 
  occlusion 95 76 126 5.33 54 
  deflation 86 70 123 4.91 55 
2 rest 77 61 123 7.57 72 
  occlusion 80 63 125 7.36 72 
  deflation 79 63 128 7.65 71 
3 rest 83 64 122 4.61 38 
  occlusion 87 68 127 4.83 41 
  deflation 88 69 130 4.85 41 
4 rest 84 66 115 6.25 59 
  occlusion 85 67 121 6.37 56 
  deflation 84 66 125 7.69 63 
5 rest 89 70 126 6.03 62 
  occlusion 96 70 124 5.63 63 
  deflation 89 71 129 6.05 63 
6 rest 99 77 122 5.35 52 
  occlusion 99 75 123 5.55 52 
  deflation 96 73 121 5.75 53 
7 rest 87 70 117 7.02 57 
  occlusion 89 72 123 7.07 54 
  deflation 86 69 122 6.65 51 
8 rest 79 55 126 7.90 58 
  occlusion 87 63 132 7.75 58 
  deflation 80 57 129 7.60 55 
9 rest 83 62 119 6.83 64 
  occlusion 82 62 118 6.39 60 
  deflation 79 58 115 7.06 63 
10 rest 90 68 124 10.06 77 
  occlusion 95 72 132 10.51 78 








Table 2b: Average baseline, occlusion and deflation blood pressure and heart rate during 
the superficial femoral artery five-minute occlusion protocol (n=10) 
Subject   MAP DBP SBP Q Heart rate 
1 rest 89 71 130 6.61 55 
  occlusion 87 70 123 6.47 57 
  deflation 87 70 129 7.14 59 
2 rest 84 67 123 5.31 50 
  occlusion 92 72 131 5.54 52 
  deflation 85 66 129 5.87 51 
3 rest 84 66 120 4.37 41 
  occlusion 91 73 128 4.45 41 
  deflation 85 68 123 4.46 41 
4 rest 87 69 123 5.87 52 
  occlusion 90 71 128 6.17 53 
  deflation 88 69 129 6.54 54 
5 rest 92 73 130 5.41 59 
  occlusion 90 71 128 5.22 56 
  deflation 90 71 130 5.65 59 
6 rest 96 74 134 6.37 58 
  occlusion 97 74 137 6.60 59 
  deflation 95 72 136 6.79 59 
7 rest 90 73 124 6.18 48 
  occlusion 92 75 128 6.54 51 
  deflation 88 71 126 7.06 52 
8 rest 79 57 124 7.41 59 
  occlusion 85 63 129 7.08 57 
  deflation 82 60 129 7.61 59 
9 rest 82 61 117 6.32 60 
  occlusion 84 63 119 6.66 63 
  deflation 82 62 119 6.79 64 
10 rest 98 76 137 9.78 76 
  occlusion 100 77 140 10.4 79 










Table 2c: Average baseline, occlusion and deflation blood pressure and heart rate during 
the superficial femoral artery two-minute occlusion protocol (n=9) 
Subject   MAP DBP SBP Q 
Heart 
rate 
1 rest 86 72 117 3.81 49 
  occlusion 88 74 119 4.11 54 
  deflation 93 78 124 4.05 51 
2 rest 101 80 138 5.47 54 
  occlusion 104 82 146 6.49 60 
  deflation 101 79 144 5.53 52 
3 rest 89 72 125 3.87 37 
  occlusion 92 73 130 4.19 38 
  deflation 83 67 117 3.84 38 
5 rest 85 66 121 4.45 54 
  occlusion 87 68 125 4.68 57 
  deflation 86 68 125 4.73 56 
6 rest 99 74 141 6.31 59 
  occlusion 101 75 143 6.22 59 
  deflation 97 73 138 6.15 58 
7 rest 92 75 125 5.70 45 
  occlusion 96 80 131 5.58 47 
  deflation 93 77 129 5.96 50 
8 rest 84 63 127 7.20 61 
  occlusion 86 63 131 6.92 56 
  deflation 84 62 128 7.12 59 
9 rest 81 63 113 6.11 64 
  occlusion 82 63 115 6.24 62 
  deflation 83 63 118 6.96 66 
10 rest 98 75 136 10.39 78 
  occlusion 100 78 136 10.30 83 











Table 2d: Average baseline, occlusion and deflation blood pressure and heart rate during 
the POP 5min occlusion protocol (n=10) 
Subject   MAP DBP SBP Q 
Heart 
rate 
1 rest 85 65 121 5.35 52 
  occlusion 84 65 120 5.11 51 
  deflation 82 64 119 5.51 54 
2 rest 70 56 98 6.27 69 
  occlusion 75 59 106 6.90 70 
  deflation 73 57 105 7.13 70 
3 rest 86 67 117 4.21 40 
  occlusion 85 66 117 4.13 39 
  deflation 82 64 118 4.31 40 
4 rest 87 69 122 5.55 56 
  occlusion 89 71 124 5.66 58 
  deflation 87 69 124 6.18 58 
5 rest 87 67 130 5.57 58 
  occlusion 87 67 130 5.50 57 
  deflation 84 64 130 5.77 58 
6 rest 95 81 123 5.87 63 
  occlusion 95 81 123 6.18 62 
  deflation 95 80 126 6.72 65 
7 rest 88 72 117 6.00 50 
  occlusion 90 74 120 5.90 52 
  deflation 88 73 124 6.22 51 
8 rest 87 65 135 8.62 67 
  occlusion 83 61 124 8.28 68 
  deflation 80 59 119 8.16 69 
9 rest 84 66 111 6.29 67 
  occlusion 91 71 121 6.77 70 
  deflation 90 70 121 6.8 71 
10 rest 94 80 121 9.57 83 
  occlusion 96 81 127 10.29 81 










Table 2e: Average baseline, occlusion and deflation blood pressure and heart rate during 
the POP 2min occlusion protocol (n=8) 
Subject   MAP DBP SBP Q 
Heart 
rate 
1 rest 94 74 127 4.85 50 
  occlusion 90 72 127 4.96 52 
  deflation 92 73 130 5.14 52 
2 rest 79 59 119 5.58 69 
  occlusion 80 61 117 6.72 71 
  deflation 77 57 117 6.09 68 
4 rest 92 73 131 5.82 56 
  occlusion 88 70 126 5.73 60 
  deflation 88 69 128 6.14 62 
5 rest 89 69 127 4.99 56 
  occlusion 87 68 126 5.00 56 
  deflation 87 68 128 5.12 56 
6 rest 95 73 134 6.01 60 
  occlusion 99 78 141 5.94 65 
  deflation 96 75 137 6.00 64 
8 rest 76 57 116 7.15 59 
  occlusion 82 61 127 8.37 66 
  deflation 82 61 128 8.61 66 
9 rest 84 66 110 6.66 71 
  occlusion 90 70 119 5.99 63 
  deflation 87 68 116 6.63 69 
10 rest 93 80 121 9.63 78 
  occlusion 92 81 124 9.98 90 







Table 3: Percent flow-mediated dilation, shear stress and flow-mediated dilation normalized to shear stress area under the 











FMD Shear stress Area Under the Curve FMD/SSAUC Peak Shear Stress 
SFA5  SFA2  POP5  
POP
2  SFA5 SFA2 POP5  POP2 SFA5 SFA2 POP5 POP2 SFA5  SFA2  POP5  POP2  
1 0 3.38 4.4 11 3290.86 1210.28 7324.18 3572.46 0 0.002793 0.0006 0.003079 202.95 72.31 467.46 213.90 
2 0.66 0 6.31 0 1970.27 925.43 7092.02 4409.68 0.00033 0 0.00089 0 123.26 69.36 391.66 272.00 
3 3.8 0 4.02   1915.74 1717.23 4492.60   0.00198 0 0.00089   137.64 127.16 282.53   
4 0   5.63 9.2 2561.50   5118.97 2604.82 0   0.0011 0.003532 153.11   337.06 204.48 
5 0 2.40 4.52 5.61 2088.12 679.15 3776.09 1907.19 0 0.003534 0.0012 0.002942 138.67 51.12 274.11 132.67 
6 0 2.25 16.50 4.74 3948.49 3512.25 8674.59 8139.68 0 0.000641 0.0019 0.000582 221.67 256.63 583.01 536.69 
7 6.3 0 7.97   7703.47 3807.29 5061.40   0.00082 0 0.00157   491.36 242.02 373.89   
8 4.52 0.00 4.61 0.00 7100.57 3428.62 6946.59 2975.55 0.00064 0 0.00066 0 448.76 288.22 459.87 177.81 
9 0.98 0.00 2.40 2.34 4082.72 3280.85 6777.92 4039.54 0.00024 0 0.00035 0.000579 271.94 257.04 486.82 296.30 
1




Table 4: Flow mediated dilation and time to peak flow mediated dilation determined using the edge-detection and center-










Table 5: Data associated with Bland-Altman plot (figure 29). Mean flow-mediated dilation using method 1 and method 2 as 
well as the difference between the two methods 
Subject M1 M2 Mean Difference 
1 10 1 5.5 9 
2 17.6 20.5 19.05 -2.9 
3 16 23 19.5 -7 
4 6.5 14.2 10.35 -7.7 
5 15.8 11.8 13.8 4 
6 1.4 6.6 4 -5.2 
7 8.5 13.1 10.8 -4.6 
 
 
Subject Measurement FMD TFMD 
1 M1 10.0 75 
1 M2 1.0 75 
2 M1 17.6 45 
2 M2 20.5 45 
3 M1 16.0 90 
3 M2 23.0 60 
4 M1 6.5 90 
4 M2 14.2 75 
5 M1 15.8 45 
5 M2 11.8 45 
6 M1 6.6 60 
6 M2 1.4 60 
7 M1 8.5 45 




 Table 6: Literature review of flow-mediated dilation protocols 












Doshi et al. 2001 
10 ♂ 34 + 5 BA Distal 250 5 L-NNMA 7.25 0 
   Proximal 250 5  11.62 7.51 
Mullen et al. 2001 
14♂ 4♀ 35 + 1.7 RA Distal 300 5 L-NMMA 5.3 0.7 
      Aspirin 4.7 4.9 
Joannides et al. 
1995 
10♂   6♀ 24+1 RA Distal 180 3 L-NMMA 3.6 -2.8 
      Aspirin 3.9 3.9 
Thijjsen et al. 
2008a 
20 ♂ 31+ 7 
RA Distal > 200 5 N/A 9.4 N/A 
BA Distal > 200 5 N/A 7 N/A 
CFA Distal > 200 5 N/A 3.9 N/A 
SFA Distal > 200 5 N/A 6.9 N/A 
PA Distal > 200 5 N/A 6.1 N/A 
Betik et al. 2003 8 ♂ 20.5+0.9 
BA Wrist 200 5 N/A 1.1 N/A 
 Forearm 200 5 N/A 3.4 N/A 
 
Upper 




Black et al. 2008 
6 ♂     6 ♀ 26.2+3.3 BA Distal >200 5 N/A 7.8 N/A 
6 ♂     6♀ 
trained 58+5.1 BA Distal >200 5 N/A 6.4 N/A 
6♂     6♀ sed. 57.3+3.9 BA Distal >200 5 N/A 5.2 N/A 
Thijjsen et al. 
2008b 
45♂ 10+1 BA Distal >200 5 N/A 11.2 N/A 
31♂ 28+6 BA Distal >200 5 N/A 7.3 N/A 
22♂ 58+5 BA Distal >200 5 N/A 6.0 N/A 
Sorsen et al. 1993 
30 7 to 17 SFA Distal 250 4.5 N/A 7.5 N/A 
30-FH 7 to 17 SFA Distal 250 4.5 N/A 1.2 N/A 
Walther et al. 
2008 
10 ♂ 25+1 BA Distal 
supra-
systolic 5 N/A 8 N/A 
  SFA Distal 
supra-
systolic 5 N/A 2 N/A 
10♂ swim 22+1 BA Distal 
supra-
systolic 5 N/A 10 N/A 
  SFA Distal 
supra-
systolic 5 N/A 8 N/A 
10 ♂-cyclists 25+1 BA Distal 
supra-
systolic 5  14  
  SFA Distal 
supra-




Kooijman et al. 
2008 
8 ♂ 34+4 SFA Distal 220 5 L-NMMA 4.2 1 
6 ♂ 34+4    10 L-NMMA ~5 ~5 
6 ♂ SCI 37+4 SFA Distal 220 5 L-NMMA 8.2 2.4 
Nishiyama et al. 
2007 
12 ♂ 27 +2 BA Distal >250 5  6.5  
  PA 
Distal-
calf >250 5  4.5  
  BA Distal >250 1+Exer  7.6  
Padilla et al. 2009 
10 ♂     1 ♀ 23.6+1.6 BA Distal 
Arm 
hanging
, 220 5  ~3.5  
  BA Distal 220 5  ~6  
  PA 
Distal-
calf 220 5  ~4  




220 5  ~3.5  
Gaenzer et al. 
2001 
10♂ 39.6+5.8 BA Distal 250 4  7.7  
8 ♂ smoker 38.9+4.1 BA Distal 250 4  4.1  
Rakobowchuk et 




Padilla et al. 2008 
10♂    10♀ 25.3+0.6 BA distal 250 1  1.5  
     2  3  
     3  4.5  
     4  5.5  
     5  7  
Gokce et al. 2003 
34♀ 130♂ NO 
CVD event 65+11 BA Proximal >200 5  7  
11♀ 24♂ CVD 
event 70+10 BA Proximal >200 5  4.4  
Celermajer et al. 
1992 
10♂      4♀ 27+2 BA Distal 300 4.5  11  
  SFA Distal 300 4.5  4  
7♂ 1♀ 
smokers 44+5 BA Distal 300 4.5  4  
  SFA Distal 300 4.5  0  
6♂ 1♀ CAD 61+2 BA Distal 300 4.5  0  
  SFA Distal 300 4.5  1  
9♂ 7♀ 11.5+0.4 BA Distal 300 4.5  9  
4♂ 6♀ FH 11.3+0.8 BA Distal 300 4.5  0  
115 
 
Silber et al. 2004 
9♂ 15♀ 27+6 SFA Distal 
SBP+ 
20 
mmHg 5  3.5  
  BA Distal 
SBP+ 




Table 7a: Correlation coefficients associated with data obtained from the reproducibility 
study 
 Baseline Diameter Time to peak 
Diameter 















BA 0.4056 0.4059 0.97 69 60 0.66 0.433 0.430 0.93 4.3 8.4 0.55 
SFA 0.648 0.642 0.99 72 66 0.63 0.659 0.662 0.99 1.6 3.1 0.77 
PA 0.648 0.653 0.98 56 56 1 0.692 0.690 0.98 6.7 5.5 0.66 
 
Table 7b: Correlation coefficients associated with data obtained from the reproducibility 
study  










r Day1 Day2 r Day1 Day2 r 
BA 708 798 0.56 13 11.4 0.90 11555 12913 0.60 
SFA 10.6 13.2 0.30 326 393 0.31 5116 5991 0.20 
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Figure 8: Bland Altman plot of the difference in brachial artery baseline diameter as a 
function of the mean diameter between testing day one and two 
Average Peak D iameter (cm)




























Figure 9: Bland-Altman plot of the difference in brachial artery peak diameter after five-
minutes of distal occlusion as a function of the mean peak diameter between testing day 
one and two 
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Figure 10: Bland-Altman plot of the difference in superficial femoral artery baseline 
diameter between testing days as a function of mean baseline diameter. 
Avergae peak d iameter (cm)


























Figure 11: Bland-Altman plot of the difference in superficial femoral artery peak diameter 
as a function of mean peak diameter between testing days 
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Figure 12: Bland-Altman plot of the difference in popliteal artery baseline diameter as a 
function of mean baseline diameter measured between testing days 
Avergae peak d iameter (cm)




























Figure 13: Bland-Altman plot of the difference in popliteal artery peak diameter as a 
function of mean peak diameter measured between testing days 
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Appendix 7: Table 9a- Reproducibility study data for the Brachial, Superficial Femoral and 
Popliteal Artery 
















S1 0.4068 0.4050 60 45 0.4095 0.4401 0.64 8.67 
S2 0.3895 0.4096 90 105 0.4672 0.4363 6.53 19.97 
S3 0.4813 0.4721 75 45 0.5205 0.5055 7.06 8.15 
S4 0.4018 0.4004 60 60 0.3963 0.3945 -1.49 -1.35 
S5 0.3485 0.3425 60 45 0.3716 0.3716 8.49 6.61 
SFA 
S1 0.6190 0.5997 75 60 0.6055 0.6133 -2.17 2.27 
S2 0.7488 0.7479 60 45 0.7955 0.7890 6.23 5.49 
S3 0.5995 0.5942 60 60 0.6242 0.6440 4.11 8.38 
S4 0.5771 0.5689 75 90 0.5824 0.5745 0.91 0.98 
S5 0.6987 0.6993 90 75 0.6894 0.6886 -1.33 -1.54 
PA 
S1 0.5949 0.6229 60 60 0.693 0.6691 16.49 7.42 
S2 0.7415 0.7344 45 45 0.7670 0.7745 3.44 5.46 
S3                 
S4 0.5967 0.5973 45 45 0.6010 0.5996 0.72 0.38 




Appendix 7: Table 9b- Reproducibility study data for the Brachial, Superficial Femoral and 
Popliteal Artery 
 Artery   




PS2   
(s-1) 
TPS2 
(s) AUC1 FMD1/AUC AUC2 FMD2/AUC 
BA 
S1 611.11 13 724.74 12 9786.01 6.59E-05 11942.56 7.26E-04 
S2 905.67 17 852.54 13 15664.32 4.17E-04 13798.44 1.45E-03 
S3 558.93 9 803.46 10 8701.41 8.12E-04 12858.47 6.34E-04 
S4 781.27 14 917.46 11 12783.96 -1.16E-04 14612.00 -9.26E-05 
S5 684.39 12 693.60 11 10841.36 7.84E-04 11354.09 5.82E-04 
SFA 
S1 221.67 10 296.11 12 3948.49 -5.51E-04 5065.62 4.49E-04 
S2 491.36 15 263.31 12 7703.47 8.09E-04 3979.65 1.38E-03 
S3 448.76 9 630.38 16 7100.57 5.79E-04 8958.67 9.35E-04 
S4 281.7 10 467 15 4082.72 2.22E-04 7278.29 1.35E-04 
S5 190.09 9 311.6 11 2747.21 -4.85E-04 4674.26 -3.29E-04 
PA 
S1 583.01 7 408.99 14 8674.59 1.90E-03 6880.11 1.08E-03 
S2 373.89 10 298.81 14 5061.40 6.80E-04 4984.45 1.10E-03 
S3                
S4 373.89 10 328.33 8 6777.92 1.06E-04 4687.07 8.18E-05 
S5 403.11 10 396.97 7 5590.51 1.29E-03 6175.72 1.45E-03 
 
 
